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The present thesis is a result of ideas created on the basis of findings in other studies 
showing that; 
⎯ people with disturbances in their calcium homeostasis often have low levels of 
vitamin D and are overweight (2-4) 
⎯ people with both primary and secondary hyperparathyroidism in general weigh more 
compared to controls (5, 6)  
⎯ there is an association between calcium, parathyroid hormone (PTH), vitamin D and 
body weight (7-11) 
⎯ cigarette smoking suppresses the levels of PTH (12-14), and may also suppress the 
levels of 25-hydroxyvitamin D (25(OH)D, also called calcidiol) (13)  and 1,25-
dihydroxyvitamin D (1,25(OH)2D, also called calcitriol) (13, 14) 
⎯ smokers have lower bone mineral density (BMD) compared to non-smokers (15, 16) 
 
 Based on the findings mentioned above, we found reason to believe that there might 
be a causal relationship between disturbances in calcium homeostasis and overweight, and 
that higher doses than the recommended daily dosage of vitamin D probably would lead to 
weight loss. Thanks to the Tromsø Study, large databases were available for studying the 
relations between PTH, anthropometric measures, BMD and body fat, and to assess the 
impact of smoking on these relations, in both cross-sectional and longitudinal designs. In 
order to test our hypothesis that high doses of vitamin D will lead to weight loss, we did a 
randomized, placebo-controlled intervention study with high doses of cholecalciferol in 
persons with body mass index (BMI) 28.0-47.0 kg/m2.  
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1.2 PTH, vitamin D and calcium homeostasis 
A normal functioning calcium homeostasis is essential for most functions in the 
human body. The two main regulators of calcium homeostasis are PTH and vitamin D.  
PTH is a polypeptide consisting of 84 aminoacids (Figure 1), and is secreted from the chief 
cells in the parathyroid glands primarily in response to low extracellular calcium levels (17). 
The secretion of PTH is also stimulated by elevated levels of phosphate, whereas the secretion 
of PTH is suppressed by high extracellular calcium concentrations. The extracellular calcium-
ion-sensing receptors (CaR) on the surface of the parathyroid cells sense the ionized serum 
calcium concentration, and regulate the secretion of PTH in response to minor changes in the 
extracellular calcium level (18).  
 
Figure 1. Structure of parathyroid hormone 
 
 
PTH is synthesized as a preprohormone, of which the pre-sequence is crucial for 
passage through the membrane of the endoplasmic reticulum. Before incorporation of the 
mature PTH into secretory vesicles, the pro-sequence is cleaved off (17). In addition to the 
full length hormone PTH(1-84), also C-terminal fragments of PTH are secreted from the 
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parathyroid glands. The biologically active hormone is the full sequence of 84 aminoacids, 
PTH(1-84). However, in the circulation there are relatively high concentrations of 
heterogeneous C-terminal fragments which do not interact with the PTH-receptor 1 (PTHR1), 
but there is evidence that also these fragments have biological activity. Intact PTH is cleared 
by the liver and by the kidneys, and the liver also generates C-terminal PTH fragments which 
can reenter the circulation (19).  
PTH regulates calcium homeostasis in several ways (Figure 2, next page).  It 
stimulates the activity of osteoblasts and stromal cells, thereby enhancing the production of 
receptor activator of nuclear factor-kappa B ligand (RANKL), macrophage colony-
stimulating factor and possibly other cytokines as well,  and it reduces the production of 
osteoprotegerin (an antiresorptive protein). This leads to differentiation of osteoclast 
precursors and stimulation of the resorbing activity of mature osteoclasts, culminating in bone 
resorption which releases calcium and phosphate into the circulation (19). PTH also 
stimulates calcium absorption from the intestine, mainly by an indirect mechanism via the 
kidneys, but probably also via a direct effect on the intestine, at least in some pathological and 
pharmacological conditions.  In addition, PTH increases renal tubular reabsorption of calcium 
(19).  By stimulating 1-α-hydroxylase in the kidney, PTH stimulates the conversion of 
25(OH)D to 1,25(OH)2D, the latter of which further increases gastrointestinal calcium 
absorption (20). In addition to this indirect effect of PTH, via the kidneys, on intestinal 
calcium absorption, there is experimental evidence for a direct effect of PTH on the intestine. 
However, at present, the role of the direct effect of PTH on intestinal calcium absorption 
under physiological conditions is unknown (19). In the kidneys, PTH stimulates the excretion 
of phosphate via a direct mechanism. PTH also inhibits 24-hydroxylase which inactivates 




Figure 2. Regulation of calcium homeostasis by PTH and vitamin D 
 
 
Parathyroid hormone related peptide (PTHrP) shares N-terminal aminoacid sequence 
homology with PTH. In addition to being responsible for the hypercalcemia of malignancy 
syndrome, PTHrP has several important physiological roles in the human body (e.g. 
regulation of chondrocyte growth and differentiation in the growth plates of developing long 
bones, branching morphogenesis of the mammary gland, mobilizing calcium from bones and 
into breast milk under lactation, regulation of maternal calcium transport across the placenta 
to the fetus) (17, 21, 22).  PTHrP is produced locally in many tissues, it seems to function 
more like an autocrine-paracrine system in which high concentrations of PTHrP are 
elaborated rapidly and cleared quickly (17, 22).  Usually PTHrP is not found in the 
circulation, except in certain conditions as hypercalcemia of malignancy or in lactating 
women. Its regulation is at the level of PTHrP mRNA expression. 
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In spite of the divergent tasks of PTH and PTHrP, the two peptides share the same G-
protein coupled receptor, the PTHR1 (also referred to as PTH/PTHrP- related receptor 
(PPR)). The PTHR1 is highly expressed in bone and kidney, but is also found in other tissues 
such as breast, skin, heart, blood vessels and pancreas, among others, which implies that the 
receptor exhibit the capacity of multiple signalling pathways (19). 
 
On average, an adult consumes about 1000 mg calcium per day, of which 40-50% is   
absorbed from the intestine. About 200-300 mg of the absorbed calcium is lost via intestinal 
and pancreatic secretions and via bile into the intestinal tract. Thus, there is a net absorption 
of approximately 100-200 mg calcium per day (23). Figure 3 displays an overview of the 
extracellular calcium homeostasis.   
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There are two mechanism for calcium absorption; the vitamin D dependent, which has 
a maximum, and the vitamin D independent passive diffusion, which does not have a 
maximum but is dependent on the calcium gradient (i.e. the calcium intake) (24). Roughly 
99% of all calcium and most of the phosphate in the human body are incorporated in the 
skeleton as hydroxyapatite, however, it is the small fractions of ionized calcium and inorganic 
phosphate in plasma which are under hormonal control (principally by PTH and vitamin D). 
Of the calcium in plasma, 40% is bound to albumin, 15% is in complex with citrate, sulphate 
or phosphate, and 45% is as the physiologically important ionized calcium. Phosphate in 
plasma exists as phospholipids, ester phosphates and inorganic phosphates (the latter as the 
ions HPO42- or H2PO4-).  
 
Vitamin D, the other main regulator of calcium homeostasis, is also called calciferol, 
and is a group of lipid soluble compounds with a four-ringed cholesterol backbone. The two 
main forms of vitamin D are vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol) 
(Figure 4). Vitamin D3 is formed in the skin when 7-dehydrocholesterol in the epidermis is 
exposed to sunlight or ultraviolet B radiation (UVB) (wave length 290-315 nm) (25). In the 
liver, vitamin D is hydroxylated into 25(OH)D and then in the kidney, by 1-α-hydroxylase, 
into 1,25(OH)2D (24). The latter compound is metabolically active. When there is sufficient 
availability of 1,25(OH)2D, then 24,25-dihydroxyvitamin D (24,25(OH)2D) is formed in the 
kidney and catabolized further. In the circulation the vitamin D metabolites are bound to the 
vitamin D binding protein, which expresses high affinity for 25(OH)D, 1,25(OH)2D and 
24,25(OH)2D and has a high homology with albumin. On entering the cell, 1,25(OH)2D binds 
to the vitamin D receptor (VDR). The  1,25(OH)2D-VDR-complex forms a heterodimer with 
the retinoid receptor, which then binds to a vitamin D responsive element on a responsive 
gene, leading to transcription, translation and either upregulation or downregulation of gene 
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products, as for example calcium binding protein. Calcitriol can also act in a much quicker 
way via a plasma membrane receptor and second messengers (24). The formation of 
1,25(OH)2D is stimulated by PTH, and inhibited by calcium via negative feedback which 
decreases PTH secretion. In addition, 1,25(OH)2D itself directly inhibits the secretion of PTH 
(24). Both 1,25(OH)2D and 25(OH)D can be degraded by 24-hydroxylase (26).  
Vitamin D increases the serum calcium concentration in three ways: 1) it induces 
proteins involved in active intestinal calcium absorption and stimulates active intestinal 
absorption of phosphate, 2) it stimulates osteoblasts to produce RANKL, which in turn 
stimulates osteoclastogenesis and bone resorption (both vitamin D and PTH is required for 
this) and 3) it interacts with PTH in the distal renal tubule to reabsorb filtered calcium (26) 
(Figure 4, next page). 
 
The serum levels of vitamin D are influenced by age, gender, race, obesity, diet, 
malabsorption, season, geographical latitude and altitude (24, 27, 28). Apart from the main 
source of vitamin D which is sunshine, the other sources of vitamin D comes from nutrients in 
the form of ergocalciferol from plants and cholecalciferol from animal products (fatty fish, 
eggs, fortified diary products). In general 25(OH)D is the preferred compound for assessment 
of vitamin D status. The concentration of 25(OH)D is about 1000-fold that of  1,25(OH)2D, 
its half-life is much longer and the concentration of  25(OH)D is more stable than that of 
1,25(OH)2D (29). Vitamin D insufficiency and deficiency is common in the general 
population in Europe and USA, particularly among adolescents and the elderly (24, 30). 
Serum concentration of 25(OH)D < 25 nmol/L are regarded as deficiency, and 25(OH)D 
levels between 25 and 50 nmol/L as insufficiency. However, there is no consensus of which 
serum level of 25(OH)D is adequate, though recently levels above 80-100 nmol/L were 
advocated (29). Some experts state that ingestion of minimum 1000 IU of vitamin D3 daily is 
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necessary to maintain the circulating concentration of 25(OH)D ≥ 75 nmol/L (27, 31), a dose 
much higher than the current daily recommended intake in Norway of 300-400 IU. The 
average daily intake of vitamin D in adults in Northern Norway is close to 400 IU (9.9 μg) 
(32). 
 
Figure 4. Synthesis and metabolism of vitamin D in the regulation of calcium, phosphorus, 
and bone metabolism (Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-



















Hyperparathyroidism is characterized by disturbances in calcium homeostasis. In 
primary hyperparathyroidism (PHPT) there are increased serum concentrations of calcium 
and PTH, the most common cause of which is parathyroid adenoma (33, 34). In secondary 
hyperparathyroidism (SHPT) there is hypocalcemia (or normocalcemia), hyperphosphatemia 
and low serum concentration of 25(OH)D resulting in increased secretion of PTH, the most 
common cause of which is chronic kidney disease (35, 36). Tertiary hyperparathyroidism 
ensues in longstanding SHPT which leads to parathyroid gland hyperplasia with autonomous 
secretion of PTH and elevated levels of serum calcium and phosphate, the latter often grossly 
so. In addition to other features, hyperparathyroidism is often associated with reduced BMD. 
 
 
1.3 Bone structure and remodelling 
There are two main components determining bone strength; composition and structure 
(37). In addition to the support of the body, the skeleton plays a major role in calcium 
homeostasis, functioning as a reservoir of calcium and phosphate (as described above), and it 
protects internal organs and houses the bone marrow (38). Bone is composed of type I 
collagen stiffened by calcium hydroxyapatite crystals. The human skeleton is about 60% 
mineralized (37). The skeleton consists of two types of bone; cortical and trabecular. Cortical 
bone constitutes about 80% of the skeleton, and is located mainly in the shafts of long bones 
and at surfaces of flat bones. This compact bone is laid down concentrically around central 
canals or Haversian systems (38). Long bones are constructed for lightness and to favour 
rigidity over flexibility, making them suitable for their functions for loading and movement. 
This is achieved by placing the cortical mass distant from the long axis and by the presence of 
the marrow cavity (37). Trabecular or cancellous bone is mainly found at the ends of long 
bones, vertebral bodies and at the inner parts of flat bones. This type of bone consists of an 
 17
interconnecting meshwork of plates and bars wherein the bone marrow is located (38). The 
trabecular structure promotes lightness and  favour flexibility over stiffness, properties 
advantageous for their function as “springs” or shock absorbers, being able to absorb more 
energy by deforming more before cracking than long bones are able to (37).  
 
There are three types of bone cells; osteoclasts, osteoblasts and osteocytes. Osteoclasts 
resorb bone, whereas osteoblasts produce new bone. Osteocytes are osteoblasts which are 
buried within lacunae in the mineralized matrix. They probably act as mechanosensors and 
locate both the place and time in which bone remodelling is necessary. Another faith of 
osteoblasts after finishing bone formation is becoming flat lining cells, covering the quiescent 
bone surface. The cell types communicate with each other and the surroundings via a 
syncytium of cellular extensions. The basic multicellular unit (BMU) is responsible for bone 
remodelling. It consists of osteoclasts in the front, osteoblasts in the rear, a central capillary, 
nerve supply and connective tissue (39). In the BMU osteoclasts resorbs bone and then 
osteoblasts produce and lay down osteoid where the resorbed bone was. Finally the osteoid is 
mineralized. This is a coupled process; resorption always preceding formation. At any given 
time about 20% of the cancellous bone in adults is undergoing remodelling (38), and every 
ten years the adult skeleton is being completely remodelled (39).  
 
There are differences in bone structure during growth and aging between females and 
males and between different ethnic groups (37, 40). The bones in females have a smaller 
diameter and are shorter with slightly thinner cortices compared to those of men, resulting in a 
smaller and lighter skeleton. These differences are explained by the more rapid growth of the 
appendicular skeleton than the axial skeleton before puberty and the later onset of puberty in 
males (37). When estrogen levels in women decrease quite rapidly on entering menopause, 
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bone remodelling rate and bone resorption increases, leading to net bone loss. Estrogen 
deficiency induces apoptosis of osteoblasts and prolonged viability of osteoclasts. During 
senescence in men, the age-related bone loss is more slowly than in women because of slower 
decrease in sex hormones. The ratio and the mode of bone apposition and resorption with 
aging also differ between sexes, resulting in trabecular loss in women and thinning in men. 
These facts might explain why women are more prone to fragility fractures and osteoporosis 
than men (38, 40, 41). Estrogen, in both genders, and in men also testosterone, is important 
for development of peak bone mass. However, estrogen deficiency is the major determinant of 
age-related bone loss in both sexes (42). 
 
When there is an imbalance in bone remodelling with more resorption than formation, 
osteoporosis will eventually develop. In osteoporosis there is destruction of microarchitecture 
and low bone mass, predisposing for fragility fractures (39-41). Using dual-energy X-ray 
absorptiometry (DEXA), the criterion for the diagnosis of osteoporosis is T-score less than -
2.5. T-score is the number of standard deviations a person’s BMD is below or above the mean 
of younger adults (43, 44). The etiology of osteoporosis is multifactorial, involving genetic, 
behavioural, nutritional and medical conditions (37, 39-44). Worldwide the incidence of 
osteoporosis is increasing as the proportion of older people is rising (40, 44). 
 
Intermittent administration of PTH has an anabolic action on bone, whereas 
continuous administration has a catabolic action due to osteoclast activation (20, 39). PTH 
given intermittently stimulates bone formation by increasing osteoblast number and activity, 
by delaying apoptosis of osteoblasts and osteocytes, and by increasing remodelling rate with a 
net positive balance. The effect of intermittent administered PTH on BMD is most 
pronounced in trabecular bone (39, 45, 46). In recent years injectable recombinant PTH has 
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emerged as an effective therapeutic agent for osteoporosis (20, 39), and at present an oral 
compound is also being tested out (47). However, in addition to other agents, supplementation 
with vitamin D and calcium is still important in the prevention and treatment of osteoporosis 
(48, 49).  
 
1.4 Body composition and obesity 
Body composition can be seen from five different perspectives; atomic, molecular, 
cellular, tissues and whole body (50). Briefly described, the atomic model is characterized by 
the 11 main elements that constitute over 99% of the body composition: oxygen, carbon, 
hydrogen, nitrogen, calcium, phosphate, potassium, sulphur, sodium, chlorine and 
magnesium. This model is useful in radiation physics, and is measured by neutron activation 
analysis combined with whole body counting. The molecular model is most used in body 
composition research, and aims to assess the relative contents of lipid, water, proteins, 
glycogen and minerals. There are three families of this model. The first is the neutron 
activation analysis-whole body counting 4-component model, which divides body 
composition into protein (nitrogen), bone mineral (calcium), fat (carbon) and water (oxygen). 
The second molecular model is the underwater weighing of the 4-component model. The 
DEXA 3-component model is the third, and includes the components fat mass (FM), lean soft 
tissue mass (LM) and bone mineral content (BMC), where LM comprises water, protein, 
glycogen and soft tissue minerals (51). Using a reference man of 70 kg, the body composition, 
in percents of his body weight, is 60% water, 20% fat, 15% protein and 5% mineral (50), 
whereas a reference woman would have the same amount of protein and mineral, but about 
50% water and 30% fat. Thus in most persons, LM makes up 70-90% of the body 
composition, and in adults there is a relationship between LM and stature (52). 
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 The cellular model comprises cells, extracellular fluids and extracellular solids, and is 
important in physiological studies. The tissue system model includes the body’s various 
tissues (muscular, connective, epithelial and nervous), organs and systems. It comprises 
adipose tissue and its subcomponents, major organs, skeletal muscle and smaller tissues and 
organs. It is useful for assessment of biological processes. Computerized axial tomography 
(CT) and magnetic resonance imaging (MRI) are used for measurement of the tissue 
components. The whole body model serves to assess body size, shape, and exterior and 
physical characteristics. There are several dimensions that can be measured according to this 
model; stature, segment lengths, body breadths, circumferences, skinfold thickness, body 
surface area, body volume, body weight, BMI and body density (50). A new technique for 
measurement of external body shape, proposed for both obesity research and clinical practice, 
is the whole-body three-dimensional photonic scanning (53). In the present thesis the DEXA 
3-component and the whole body models are used.  
 
Even though studies of body composition have been a field of research for more than a 
century (52), all factors determining body composition are not known, and there is also at 
present extensive research on the subject. The factors determining body weight and body 
composition, when there are no major environmental constraints, are not well understood 
(54). The different ways of assessing and measuring body composition and the lack of good 
prospective studies make it quite difficult to determine which, and how, factors influence 
body composition. We know that body composition is partly determined by genetic factors 
such as race, inheritance (e.g. the height of parents can be used to predict offspring height), 
gender differences, but also other factors contribute. Regarding nutrition, both positive and 
negative changes in energy balance usually involve changes in both LM and FM, and 
generally the changes are in the same direction (52). However, the relative contribution of LM 
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and FM to the total weight change is dependent of the initial content of body fat. Fatter 
persons tend to loose a higher proportion of the total weight loss as FM and thinner persons 
loose relatively more LM than FM. In intentional overfeeding, the gain in weight and the gain 
in LM are directly proportional to the amount of excess food ingested (52). Regarding 
exercise and body composition, in the absence of significant weight change, one can loose 2-3 
kg FM and gain 2-3 kg LM. Vigorous exercise resulting in more than 4-5 kg weight loss can 
also induce loss in LM. There is evidence suggesting that body composition is at least 
partially preprogrammed and influenced by early growth and nutrition. The facts that fetuses 
gain FM predominantly in the third trimester of gestation, and that offspring of diabetic 
mothers are at higher risk for macrosomia compared to offspring of non-diabetic mothers, 
suggest that adipose tissue mass and distribution may be determined by experience during 
fetal life. However, there is inconsistency regarding birth weight, nutrition and growth in 
infancy and the association with later body composition and subsequent disease risk (55).  
 
Body composition changes to a variable degree with aging. Cross sectional studies 
give the impression of a progressive decline in LM with increasing age, but in longitudinal 
studies the time change in body composition is variable (52). From birth there are gender 
differences in body composition, and the changes in body composition during development 
and ageing are primarily attributed to the levels of sex steroids (56, 57). Males generally have 
a higher ratio of muscle mass (MM) to total LM than females, attributable to higher MM, 
however, this gender difference diminishes with increasing age. Women generally have a 
higher percent FM than men, at least until the fifth decade, in which the difference starts to 
vane, as women enter the menopause and estrogen levels decline. Men tend to accumulate 
more visceral fat with age than women, but also this gender difference is smaller when older 
men are compared to postmenopausal women (56). It is proposed that testosterone favours fat 
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deposition in the trunk and abdomen, whereas estrogen facilitates fat deposition in the 
buttocks and thighs, resulting in the sex-specific fat distribution (57). In addition, the enzyme 
lipoprotein lipase (LPL) facilitates fat uptake and storage in adipose tissue. LPL levels are 
high in adipose tissue at the hip, thigh and breast in women and in the abdomen in men (57). 
BMC is equal between the sexes until about the age of 15 years, after which males by the time 
of reaching adulthood have accrued higher BMC than females, especially apparent in the 
appendicular skeleton. The age-related loss of BMC is greater in women than men. These 
differences in BMC are also attributed to the gender differences in sex hormones (42, 56).  
In men, MM declines by 20-40% between 25 to 75 years of age, the FM doubles and 
BMD decreases gradually (58). In women, the same changes are seen with ageing; decreasing 
MM and increasing FM with increasing age, however, the decrease in BMD is more abrupt in 
women, with a quicker decrease on entering the menopause (37, 40, 42, 56). 
 
Overweight and obesity are defined as abnormal and excessive body fat which may 
impair health (59). One way of assessing these conditions is by means of BMI. The World 
Health Organization’s (WHO) ranges for BMI are as follows; underweight: BMI < 18.50 
kg/m2, normal weight: BMI 18.50- 24.99 kg/m2, overweight: BMI 25.00- 29.99 kg/m2, obese: 
BMI ≥ 30.00 kg/m2 (60). Globally the prevalence of overweight and obesity has now reached 
epidemic proportions (61), and it is estimated that 1.6 billion adults above the age of 15 years 
were overweight and 400 million adults were obese in 2005 (59). Across most countries in 
Europe the BMI in the general population has increased over the last decades (starting around 
1980), and in many of the European Union Member States more than 50% of adults are 
overweight or obese (62). In Scandinavia and in the Netherlands the rise in obesity was 
delayed up to a decade compared to other European countries, primarily because of higher 
level of physical activity (63). In Norway the prevalence of obesity during the years 1995-
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2002 was about 14% (64), and the proportion of the population being obese has steadily 
increased from well below 10% in 1984 to above 15% for both sexes in 2000-2003 (65).  In 
the USA, where the prevalence of obesity is among the highest in the world, tipping 32% in 
2003-2004 (66), it is estimated that if the steadily increase in BMI in the general population 
continues, obesity will soon override smoking as the main preventable cause of illness and 
premature death (61).  
 
Obesity is associated with increased risk for cardiovascular diseases, diabetes mellitus, 
metabolic syndrome, primary and secondary hyperparathyroidism and some types of cancer 
(6, 11, 61, 66-69). It is intriguing that also vitamin D is associated with all these conditions, 
and adequate serum levels of 25(OH)D seem to be associated with a lower risk of the 
mentioned diseases (4, 25, 30, 70-72).  
Several studies have shown an inverse association between body fat and serum levels 
of 25(OH)D (2, 3, 10). Previous reports from the Tromsø Study have found a positive relation 
between PTH and BMI (9), and that SHPT frequently is caused by low calcium intake and 
low serum 25(OH)D levels (73). FM is also found to be a significant independent determinant 
of serum PTH levels in postmenopausal women (74). A higher intake of dietary calcium is 
associated both with lower body weight compared to persons with lower intake, and also with 
weight reduction in obese persons who initially had low dietary calcium intake (7, 75). 
However, not all data support a causal relationship between high diary food intake and/or high 
dietary calcium intake and lower fat mass deposition (76). Recently, even mild disturbances in 
calcium homeostasis in premenopusal women was found to be associated with obesity, lower 
BMD and decreased quality of life (77). There seems to be a positive association between 
elevated serum levels of PTH and body fat, but it is not known if the relation is causal, nor if 
PTH increases body fat or vice versa. Hence, calcium homeostasis is somehow involved in 
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the regulation of body composition and body weight, but no key for explaining the 
association(s) is yet found. 
 
The pathogenesis of obesity is not well understood, but is probably multifactorial, 
involving a complex interaction of genetic, hormonal and environmental factors. An 
evolutionary origin of obesity is possible, making the body store excessive amounts of energy 
in adipose tissue, a capacity which in earlier times was essential for survival in periods of 
food deprivation and for female fertility and viability of offspring (78). However, in today’s 
western society with food abundance, which in addition often is energy-dense, this energy 
storing leads to overweight and obesity because food scarcity is non-existent and we are much 
less physically active, thus creating a positive energy balance (79). An increase in calorie 
intake of 100-200 kcal daily in an adult with BMI 22 kg/m2 can within 3-5 years result in an 
increase in BMI to over 25 kg/m2 (62). That obesity is a complex trait is supported by studies 
searching for genetic explanations for obesity. More than 120 candidate genes and over 250 
trait loci have been shown to be associated with obesity related phenotypes (80). Appetite 
regulation is another not fully understood determinant of body composition and body weight. 
It involves a complex interaction between the central nervous system, signalling peptides and 
hormones and the gastrointestinal tract (81). The immunesystem is also implicated in the 
pathogenesis of obesity (82). As a consequence of the lack of understanding of the 
mechanisms involved in determining body composition and of the pathophysiology of 
obesity, no simple and long term efficient pharmacological or surgical treatment of obesity 
exists at present (81, 83, 84). The economical burden of obesity and its complications on the 




1.5 Cigarette smoking and other lifestyle factors 
Smoking clearly influences calcium homeostasis. Cigarette smoking reduces serum 
levels of PTH (12-14), and possibly also serum levels of 25(OH)D (13) and 1,25(OH)2D (13, 
14). Smokers generally have lower BMD compared to former and never smokers and 
smoking is a well known risk factor for hip fracture and osteoporosis (15, 16). Calcium 
absorption is generally lower in smokers than in non-smokers, and is most probably 
secondary to the suppressed levels of PTH, and possibly also to suppressed levels of 25(OH)D 
and 1,25(OH)2D in smokers (85). The mechanism by which smoking suppresses the levels of 
PTH, and maybe also the levels of calcidiol and calctriol is unknown. The lower BMD in 
smokers can be attributed to the possible suppressant effect of smoking on serum levels of 
calidiol, calcitriol and sex steroids (85), resulting in higher bone turnover. In women smoking 
has an anti-estrogenic effect, leading to formation of estrogen metabolites with minimal 
estrogenic activity (85). In both genders, smokers have higher levels of sex-hormone binding 
globulin (SHBG) compared to non-smokers (85). Smoking is also reported to impair 
osteoblast function (14), and smoking could therefore result in decreased bone formation. A 
direct toxic effect of cigarette smoking on bone and impaired blood supply to bone as a 
consequence of smoking, are also plausible mechanisms for the reduced BMD seen in 
smokers. 
 
In general, smokers have lower BMI than non-smokers (86-89). However, smokers 
tend to have a higher WHR and a shift in fat distribution to more abdominal fat over 
peripheral fat compared to non-smokers. Because of this change in body composition, 
smokers have an increased risk of diabetes mellitus, metabolic syndrome and cardiovascular 
diseases and events (86-89). Smoking is associated with higher consumption of alcohol and a 
more sedentary lifestyle compared to non-smokers (87, 89). Smoking cessation is shown to 
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give a reversal of the metabolically adverse body composition and, after several years, the fat 
distribution in former smokers approach the pattern in never smokers (86, 89).  The same 
holds for BMD, with partially regain in BMD with increasing years since smoking cessation 
(15, 91, 92).  
 
Smoking prevalence in Norway has decreased from over 50% of men and over 30% of 
women in 1973, to 24% and  23% of men and women, respectively, in 2007 (93). In 2007, 
22% of the population aged 16-74 years were daily smokers, whereas 10% in the same age 
group were occasional smokers (93). Worldwide there are about 1.1 billion smokers (94).  It 
has been estimated that if smoking prevalence is reduced to 20% by the year 2020 over 100 
million deaths due to smoking could be prevented (95). Several countries have implemented 
smoking bans, which have proven to be successful (96-98). 
 
Other lifestyle factors related to body composition are physical activity and alcohol 
consumption. Generally, people with higher levels of physical activity and moderate alcohol 
consumption exhibit a metabolic healthier body composition compared to their counterparts, 
with better preservation of MM and less FM and higher BMD (11, 99-101). 
 
Thus, there is a complex, not fully understood, relationship between calcium 
homeostasis and body composition, and the associations between the two are further 
complicated by the confounding or modifying effects of lifestyle factors such as smoking, 





2. Aims of the thesis 
The aims of the present thesis were to explore the relation of different aspects of body 
composition with calcium homeostasis and smoking by studying: 
⎯ the cross-sectional relation between BMI and smoking, and longitudinal changes in 
BMI in relation to change in smoking status 
⎯ the association between PTH and BMD, and the impact of smoking 
⎯ the association between PTH and body fat, and the impact of smoking 
⎯ the effect of 12 months of high doses of cholecalciferol, in conjunction with calcium 


















3. Subjects and methods 
3.1 Paper I, II and III 
3.1.1 Subjects 
Subjects were participants in the fifth (paper II), or both the fourth and the fifth (paper 
I and III), Tromsø Study; a population based multipurpose health survey. It has been 
conducted five times; in 1974, 1979, 1986, 1994/1995 (for simplicity 1994 in the following) 
and 2001/2002 (for simplicity 2001 in the following). The sixth Tromsø Study started in 2007 
and was still running when this dissertation was written. 
In the fourth Tromsø Study in 1994, all men and women born earlier than 1970 and 
living in the municipality of Tromsø were invited to participate. Out of 37 558 invited 
subjects, 27 158 accepted to attend the first phase of the study. The attendance rate was 77%, 
with an age distribution from 25 to 97 years. All subjects aged 55-74 years old and 5-10% 
random samples in the 25-54 and 75-85 age groups were invited to return for a second phase 
of the study with comprehensive examinations including bone densitometry.  A total of 7965 
subjects accepted the invitation to the second phase of the study. During recent years the 
Institute of Community Medicine has revised and updated their databases, and hence the 
number of invited subjects and the number of participants have changed since the writing of 
the studies presented in this thesis. 
In the fifth Tromsø Study in 2001, all men and women older than 29 years in the 
municipality of Tromsø who had participated in the second phase of the fourth Tromsø Study 
in 1994, or became 30, 40, 45, 60 or 70 years old during 2001, were invited to participate. A 
total of 10 353 persons were invited, of whom 8130 attended the first phase of the study. The 
attendance rate was close to 79%, and the age distribution was 30 to 89 years. Of the 
attendants, 6966 subjects, who had also attended the second phase of the fourth Tromsø Study 
and were still living in Tromsø, were invited to attend the second the phase of the fifth 
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Tromsø Study with comprehensive examinations as in the preceding study. A total of 5939 
persons accepted the invitation.  
 
In paper I we included subjects in whom we had anthropometric measures and 
information of lifestyle factors, including smoking status and number of cigarettes smoked 
daily.  
 
In paper II we included subjects from the fifth Tromsø Study who had eligible 
measurements of BMD, serum calcium < 2.55 mmol/L, measurement of serum PTH, and did 
not use hormone replacement therapy (HRT), contraceptive pills or medication for 
osteoporosis. 
  
In paper III we included subjects from the fourth and the fifth Tromsø Study who had 
serum calcium < 2.55 mmol/L, and in whom we had anthropometric measures, serum PTH 
levels, information about lifestyle factors including smoking status and, available in the fifth 
Tromsø Study only, DEXA measurement of body composition.  
 
3.1.2 Questionnaires 
All subjects filled in a questionnaire regarding health, smoking status, physical activity 
in spare time, alcohol and coffee consumption, use of estrogen compounds, calcium 
supplements and cod liver oil. The questionnaires used in the fourth and the fifth Tromsø 
Study can be found in Appendix A and B, respectively. 
A physical activity score was calculated as the sum of hours of light and heavy 
physical activity in spare time per week, with heavy physical activity given double weight. 
Coffee consumption was calculated as the sum of cups of all types of coffee (brewed, filtered 
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or other type) drunk per day. Alcohol consumption was calculated as the number of glasses of 
alcohol (adding glasses of spirits, beer and wine) consumed in two weeks, assuming equal 
amount of alcohol in each glass.  
 
3.1.3 Measurements 
Height and weight were measured wearing light clothing and no shoes. BMI was 
calculated as weight in kg divided by squared height in metres (kg/m2). Body composition and 
BMD at the hip were measured by DEXA (GE LUNAR Prodigy, LUNAR Corporation, 
Madison, WI, USA), whereas BMD at the forearm was measured by two single X-ray 
absorptiometric devices (SXA) (DTX-100; Osteometer Medi-Tech Inc., Hawthorne, CA, 
USA), according to the manuals provided by the manufacturers.  The coefficient of variation 
(CV) % was 1.17% and 0.9% for the DEXA and SXA measurements, respectively. 
 
3.1.4 Blood samples 
Blood samples were drawn in the non-fasting state, and analyzed at the Department of 
Clinical Chemistry, University Hospital of North Norway. A Hitachi Model 917 analyzer, 
with reagents from Boehringer Mannheim (Mannheim, FRG, Germany), was used for 
measurement of serum concentrations of calcium and creatinine. Serum concentrations of 
intact PTH were determined using an Immulite analyzer (Diagnostics Products, Los Angeles, 
CA, USA) for two-site chemiluminescent immunometric assay.  Reference ranges in our 
laboratory were for serum calcium at the time of the study 2.20- 2.60 mmol/l; for serum 
creatinine 70-120 μmol/l for men and 55-100 μmol/l for women; and  for serum PTH, 1.1-6.8 




3.1.5 Statistical analyses 
Normal distribution was evaluated with visual inspection of histograms with normal 
curve, normality plots (Q-Q-plots), and determination of skewness and kurtosis. Whenever 
the dependent variable in question was normally distributed, parametric tests were used, and 
when it was not normally distributed non-parametric tests were used.  
In general, a general linear model (GLM) was done first to check for interactions, and 
whenever an interaction was found we did stratified analyses for the variable in question 
where appropriate. Analysis of covariance (ANCOVA) was used for calculation of adjusted 
means. 
When comparing groups, we used Student’s t-test for normally distributed variables 
and Mann-Whitney or Kruskal-Wallis test for variables without normal distribution. Where 
applicable, we used a GLM for comparison of groups. Linear trend across subgroups was 
evaluated with linear regression analysis. 
For evaluation of individual predictors of a normally distributed dependent variable, 
multiple, or in some instances univariate, linear regression was used. The appropriateness of 
the models was verified by plotting the residuals against each variable and inspecting the plots 
for even distribution throughout the variable range. 
Correlations between the dependent variable and the predictor variables in question 
were evaluated either by Spearman’s rho (ρ) or by Pearson’s correlation coefficient (r), as 
appropriate. In the analyses of the longitudinal data, change in variables was calculated as the 
value in 2001 minus the value in 1994. In paper III, z-scores for PTH in 1994 and in 2001 
were calculated to give the values from 1994 and 2001 equal weight when calculating the Δ 
PTH value (Δ PTH z-score).  
Unless otherwise stated, all data are given as mean ± standard deviation (SD). All tests 
were done two-sided, and P < 0.05 was considered statistically significant. A Bonferroni 
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correction was used when multiple comparisons were done. The Statistical Package for Social 
Sciences (SPSS) was used for all analyses (SPSS Inc., Chicago, Ill., USA); SPSS 13.0 in 
paper I, and SPSS 14.0 in paper II and III.  
 
3.1.6 Ethics 
The studies were approved by the Regional Ethics Committee, and all participants 
gave written informed consent prior to the studies. 
 
3.2 Paper IV 
3.2.1 Subjects 
In paper IV the subjects were recruited either by letter after identification in hospital 
charts with the diagnosis overweight or obesity, or by advertisement in the local newspaper 
“Nordlys” and in the hospital’s official news periodical “Pingvinen”. Subjects between 21 and 
70 years old of both sexes, with BMI between 28.0 and 47.0 kg/m2, without diabetes mellitus, 
cardiovascular or psychiatric diseases or renal stone disease, and without conditions known to 
affect calcium homeostasis, as sarcoidosis, were recruited. Subjects who had lost more than 
10% of their body weight during the last six months, used anti-depressant pharmacotherapy, 
drugs for weight-reduction or participated in weight-reduction programs, pregnant or lactating 
women and fertile females not using contraceptive pills or intrauterine contraception device, 
were not eligible. Subjects with serum calcium > 2.55 mmol/L, males with serum creatinine > 
129 μmol/L and females with creatinine > 104 μmol/L were not included. In those with serum 
calcium in the range 2.50-2.55 mmol/L, serum PTH had to be < 5.0 pmol/L for inclusion. An 
oral glucose tolerance test (OGTT) was done at baseline, and persons having test results 
compatible with diabetes mellitus were excluded.  
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Trained nurses and I made telephone interview of 626 persons in order to recruit 
suitable subjects, using a questionnaire. There were 496 persons who met for screening, of 
whom 445 met our inclusion criteria and were included. Subjects were randomized, stratified 
by smoking status and gender, into three groups either receiving 20 000 IU cholecalciferol 
twice a week, 20 000 IU cholecalciferol and placebo weekly, or placebo twice a week. In 
addition, all subjects received 500 mg calciumcarbonat daily. There were six visits at the 
hospital during the study; screening, baseline and then after three, six, nine and 12 months. 
 
3.2.2 Questionnaires 
All subjects filled in questionnaires regarding physical activity, mood (Beck’s 
Depression Inventory (BDI)) and food frequency on entering the study (baseline) and at the 
end of the study at 12 months. Specially trained nurses controlled each questionnaire together 
with the participant in order to make sure that there were no misunderstandings and that all 
parts of the questionnaires were answered. The food frequency and the BDI questionnaires 
were read optically, whereas the physical activity questionnaire was punched manually by one 
specially trained nurse. Smoking status was recorded, and subjects assigned as smoker or non-
smoker.  
A physical activity score was calculated from the reported amounts of vigorous, 
moderate and walking activities during the last seven days, and displayed as multiples of the 
resting metabolic rate (MET)-minutes per week. MET are metabolic equivalent. Intakes of 
calories, vitamin D and calcium were calculated from the food frequency questionnaire. The 






Height, weight, body composition and BMD were measured, and BMI was calculated, 
as described above for papers I, II and III. Waist circumference (WC) was measured 2.5 cm 
above the umbilicus, and hip circumference (HC) was measured at the widest circumference 
at the hip. The waist-to-hip ratio (WHR) was calculated by dividing the WC by the HC. 
Height, body composition and BMD were measured at baseline and at 12 months, whereas 
weight, WC and HC were measured, and WHR and BMI calculated, at each visit. 
Glucose tolerance was assessed by OGTT; in the fasting state subjects were given 75 g 
dextrose dissolved in 300 ml water. Blood tests for determination of serum glucose and 
glycosylated adult haemoglobin 1 (HbA1c) were drawn immediately before the ingestion of 
the sugar solution, and two hours after ingestion for determination of serum glucose. Fasting 
serum glucose ≥ 7 mmol/L or two-hour value ≥ 11.1 mmol/L were evaluated as the subject 
having diabetes mellitus, and hence the person was excluded from the study.  
Urine was collected for 24 hours both at baseline and at the end of the study for 
determination of urinary calcium excretion. Urinary calcium was measured on a Modular 
P800 (Roche Diagnostics®, Mannheim, Germany), with reagents from the same company. 
The reference range for urinary calcium was 2.0-8.0 mmol/24 hours.  
 
3.2.4 Blood samples 
At baseline and at 12 months, all blood samples were drawn in the fasting state, and at 
the other visits (3, 6 and 9 months) they were drawn in the non-fasting state. Serum calcium, 
serum creatinine and plasma PTH at screening were measured consecutively, whereas fasting 
serum PTH from baseline and after 12 months were analyzed in batch at the end of the study. 
All serum 25(OH)D samples were also analyzed in batch at the end of the study. Apparatuses 
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and reagents used for analyses of calcium, creatinine and PTH, as well as reference ranges 
were as described above for papers I, II and III.  
Serum 25(OH)D3 was determined by immunometry (electrochemiluminiscence: 
ECLIA) using an automated clinical chemistry analyser (Modular E170, Roche Diagnostics®, 
Mannheim, Germany). According to the producer, the assay has, for total analytical precision, 
a CV ≤ 7.8 % as judged in any of three different concentrations (48.6-73.8-177.0 nmol/L). 
The cross-reactivity with 25(OH)D2 was <10 % and the analytical sensitivity was 10 nmol/L. 
At present, the laboratory has no reference values for 25(OH)D3, but the manufacturer 
provides a population based reference range of 27.7-107.0 nmol/L for adults as a guideline.  
 
3.2.5 Statistical analyses 
In general, statistical analyses were performed as described for papers I-III. All 
dependent variables were considered normally distributed. 
Correlations were evaluated with Pearson’s correlation coefficient r. Linear regression 
was used for evaluation of individual predictors of BMI with age, gender, serum calcium, 
serum PTH, serum 25(OH)D, calorie intake, calcium intake, vitamin D intake, smoking status 
and physical activity score as covariates. Groups were compared by Student’s t-test, applying 
Bonferroni correction for multiple analyses where appropriate. In addition, in order to 
incorporate all repeated measures, and to adjust for dependency between them, a linear mixed 
model with a Toeplitz covariance structure was used. 
 
3.2.6 Ethics 
The study was approved by the Regional Ethics Committee, and all participants gave 
written informed consent prior to the study. 
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4. Main results 
4.1 Paper I. Cross-sectional study on the relationship between body mass index 
and smoking, and longitudinal changes in body mass index in relation to change 
in smoking status. 
 
The objective in this combined cross-sectional and longitudinal study was to explore 
the relation between BMI and smoking, and to assess the effect of change in smoking status 
on BMI. A total of 10 920 men (3937 smokers) and 12 090 women (4343 smokers) from the 
fourth Tromsø Study, and 2364 men (732 smokers in 1994)  and 2738 women (942 smokers 
in 1994) who had participated in both the fourth and the fifth Tromsø Study were included. 
In the cross-sectional study we found that both male and female current smokers had a 
lower BMI, lower degree of physical activity and higher consumption of coffee and alcohol 
compared to never smokers. There was a U-shaped relation between the number of cigarettes 
smoked daily and BMI. Those smoking six to ten cigarettes daily had the lowest BMI, 
whereas never smokers and heavy smokers had similar BMI.  In the longitudinal study we 
found continuing smokers to have a smaller increase in BMI compared to those who had 
given up smoking. Among those who had quitted smoking, there was a significant positive 
relation between the number of cigarettes smoked daily in 1994 and increase in BMI.    
 
 
4.2 Paper II. The association between serum parathyroid hormone and bone 
mineral density, and the impact of smoking: the Tromsø Study. 
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In this cross-sectional study our aim was to address the relation between serum PTH 
and BMD, and to assess the impact of smoking. A total of 1442 men (341 smokers) and 1368 
women (354 smokers) from the fifth Tromsø Study were included.  
We found serum PTH to be a strong negative predictor of BMD at the hip in both 
genders, but not at the distal or ultradistal forearm. In addition, age and smoking were 
negative predictors and BMI and physical activity positive predictors of BMD at the hip. 
However, the relation between PTH and BMD at the hip was significant in current non-
smokers only when smokers and non-smokers were analysed separately. Current non-smoking 
males had significant higher BMD at the hip, distal and ultradistal forearm compared to 
smoking men. Former smoking men had BMD values at all three measurement sites in-
between current and never smoking men. There was a significant negative relation between 
the number of years smoked and BMD at the hip in both genders. Male former smokers 
showed increasing BMD values at the hip with increasing years since smoking cessation. 
There was no significant relation between BMD and neither the number of cigarettes smoked 
daily nor pack-years. The effect of smoking on BMD seemed more pronounced in men.  
 
 
4.3 Paper III. The association between serum parathyroid hormone and body fat, 
and the impact of smoking. The Tromsø Study. 
 
This work is a combined cross-sectional and longitudinal study, in which we wanted to 
explore the relation between serum PTH and measures of body fat, and the impact of 
smoking. In the cross-sectional part of the paper, 543 men (128 smokers) and 791 women 
(211 smokers) were included, whereas the longitudinal part included 639 men and 783 
women, all non-smokers.  
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We found a positive relation between PTH and fat mass (measured by DEXA), in non-
smokers only, in the cross-sectional part. There was a significant increase in age, BMI, total 
FM (kg), and percentages of total body fat, trunk fat and fat in the extremities with increasing 
PTH quartiles. In smokers there were no significant trends for measures of body composition 
across PTH quartiles. In the longitudinal study, the relation between PTH and body fat was 
assessed in continuing non-smokers only, by using BMI (DEXA-measurements were not 
available in the fourth Tromsø Study). We found a significant positive relation between 
quartiles of change in PTH from 1994 to 2001 (z-scores) and change in BMI during the same 
time period. However, there was no significant relation between quartiles of serum PTH in 
1994 and subsequent change in BMI.  
 
 
4.4 Paper IV. Supplementation with cholecalciferol does not result in weight 
reduction in overweight and obese subjects.  
 
In this prospective, randomized double blind placebo controlled study we wanted to 
evaluate the effect of one year intervention with high doses of cholecalciferol, in conjunction 
with calcium supplementation, on body weight. At baseline 159 men (34 smokers) and 286 
women (65 smokers) were included and 128 men (26 smokers) and 206 women (37 smokers) 
completed the study. During the study, two persons were diagnosed as having PHPT, another 
subject developed an increase in serum calcium to 2.62 mmol/L, and hence, all three were 
excluded. In addition, 108 participants withdraw their consent, or got excluded, because of 
various reasons (started other weight-reduction programs or pharmacological treatment for 
obesity, moved, got pregnant, time constraints, unknown reasons). There were no significant 
differences between the groups at baseline. We found a significant inverse association 
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between 25(OH)D and BMI, and a significant positive association between calorie intake and 
BMI.  During the study there was no significant weight change within, or between, the 
groups. The same was found when dividing the study population according to baseline 
25(OH)D levels. Nor were there any differences from baseline or between the groups in WHR 
or percentage body fat at 12 months. 25(OH)D increased significantly in both the 
cholecalciferol + cholecalciferol-group and in the cholecalciferol + placebo-group, and levels 
stabilized after three months and throughout the study. Serum PTH decreased significantly in 
the two groups given cholecalciferol, and serum calcium was unchanged in all three groups. 
Urinary calcium excretion increased in all three groups, but there was no significant 















5. General discussion 
The findings in the four presented papers show that there is an interwoven relationship 
between body composition and calcium homeostasis, and that body composition also is 
influenced by cigarette smoking. 
 
5.1 BMI, PTH, BMD and body fat, and the impact of smoking (Paper I, II and 
III) 
In paper I we found a U-shaped relation between the number of cigarettes smoked and 
BMI, and that smoking cessation was associated with weight gain compared to continuing 
smokers, consistent with the findings of others (102, 103). In line with other studies (86, 104, 
105), we also found current smokers to have lower BMI, lower physical activity level and 
higher coffee- and alcohol consumption compared to never smokers. Our results can be 
explained by the appetite suppressant effect and the increase in metabolic rate of smoking 
(106-108), and the unhealthier lifestyle associated with smoking compared to that of non-
smokers (86, 104, 105). The net result could in heavy smokers be that their unhealthier 
lifestyle overrides the appetite suppressant effect and the increased metabolic rate induced by 
smoking.  
We also found a positive relation between number of cigarettes smoked and amount of 
alcohol and coffee consumed, and a negative relation to levels of physical activity. Thus the 
increased amount of calories ingested in form of alcohol and the reduced energy expenditure 
in heavy smokers can result in a net positive energy balance and weight gain. Caffeine is also 
reported to augment the thermogenic effect (109-111) and the appetite reduction (106) caused 
by nicotine. In our study, smoking cessation was paralleled by a decrease in coffee 
consumption, and there was a positive association between the increase in BMI and the 
number of cigarettes previously smoked. Thus, the weight gain associated with smoking 
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cessation can be a result of increased appetite and reduced metabolic rate because nicotine 
supply is stopped, in addition to the effect of an already established sedentary lifestyle. 
Another mechanism for the weight gain after smoking cessation can be that nicotine lowers 
the body weight set point, and when smoking ceases the nicotine induced lowering effect 
disappears (112).  
 
Based on the effects of PTH on calcium metabolism and bone, one would expect an 
inverse relation between PTH and BMD. However, in epidemiological studies the relation 
between PTH and BMD is not uniform. Most (113-117), but not all (118), studies support our 
finding of a negative relation between PTH and BMD at the hip (paper II). We found PTH, 
age and smoking to be significant negative predictors, and BMI and physical activity to be 
significant positive predictors, of BMD at the hip in both genders, as expected (41, 43). 
However, when stratifying by smoking status, the relation between PTH and BMD at the hip 
was significant in non-smokers only. PTH was not a significant predictor of BMD at the distal 
or ultradistal forearm, in accordance with Szulc et al. (116). In the studies by Garnero et al. 
(118) and Szulc et al. (116), adjustment for smoking status was not done.  
When stratifying further by sex, we found that current non-smoking men had 
significantly higher BMD at the hip as well as at the distal and ultradistal forearm compared 
to smoking men, whereas no significant relations were found in women. The association 
between PTH and BMD in men was most pronounced at the hip. Former smoking men had 
BMD values at all three measurement sites in-between current and never smokers. The gender 
difference is in accordance with a large meta-analysis done by Ward and Klesges (15). We do 
not find it likely that the gender difference is caused by sex hormones, because smoking has 
an anti-estrogenic effect in women (85) and is associated with elevated testosterone levels in 
men (72).   
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It could be that toxins in cigarette smoke affect the microstructure of bone or blood 
supply to bone (15), thus leading to bone loss. The lower PTH seen among smokers compared 
to non-smokers could be an attempt from the body to spare bone from the harmful effect of 
smoking on the skeleton. However, a reduction in PTH will also lead to increased renal 
calcium loss and reduced 1,25-hydroxylation of 25(OH)D. In addition, smoking is associated 
with lower BMI (15, 86-89), earlier menopause (15) and an unhealthier lifestyle compared to 
non-smokers (15, 87, 89), all of which could lead to reduced BMD. Smoking impairs 
osteoblast function (14), and thus an inhibitory function on bone formation is also a possible 
mechanism for the reduced BMD associated with smoking (14, 15).  
We did not find any relation between BMD and neither number of cigarettes smoked 
daily, nor pack-years, which can be attributable to information bias. However, we found a 
significant relation between BMD at the hip and number of years smoked in former smokers 
in both genders, and in men, also with the number of years since smoking cessation. The 
partially reversible harmful effect of smoking on bone seen after smoking cessation is 
supported by other studies (15). 
 
The positive relation between PTH and FM observed in our study (paper III), is also 
shown previously by others (3, 74, 119), and was expected based on our own earlier findings 
in paper II and previous reports from the Tromsø Study (9). However, in contrast to Snijder et 
al. (119), we found a significant relation between FM and PTH in non-smokers only, but 
Snijder et al. found that the relation became 10% stronger when adjustment for smoking was 
done. In accordance with Snijder et al., we found a strong association between PTH and total 
body and trunk fat, but we found in addition a significant relation between PTH and fat in the 
extremities. This difference can be attributed to the higher number of subjects in our study. 
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Across increasing PTH quartiles we found a significant increase in age, BMI, total FM (kg), 
and percent total body fat, trunk fat and fat in the extremities in non-smokers, but not in 
smokers. We did not find any relation of PTH with LM. The masking effect of smoking on 
the association between PTH and body fat is difficult to explain. 
One explanation for the increased FM associated with increased levels of PTH might 
be that PTH is reported to impede cathecholamine induced lipolysis i adipocytes (11) and by 
increasing intracellular calcium ion concentrations in adipocytes, elevated PTH levels can 
enhance lipogenesis (75). Zemel states that dietary calcium has anti-obesity effects (75), and 
this is supported by others (120, 121). It is shown that dairy calcium affects body weight to a 
greater degree than calcium supplementation does (75), probably because dairy products are 
fortified with vitamin D in many countries. However, there is also contradictory evidence 
(76). We found a weak, significant association between change in serum PTH (Δ PTH z-
scores) and BMI in the longitudinal study in paper III. This may indicate a causal relationship 
between PTH and body fat, but if it exists, it is probably of low clinical significance. It has to 
be addressed that BMI is only a surrogate marker for fat distribution, and it is possible that we 
had found different results if DEXA-measurements of body composition were available in the 
fourth Tromsø Study also.  
 
Further support for the hypothesis that there is connection between calcium 
homeostasis and body composition comes from the finding that adipocytes and osteoblasts 
arise from the same progenitor cell (122). It has been suggested that osteoporosis is the 
obesity of bone, as there is evidence suggesting that fat infiltration in the bone marrow is 
associated with skeletal fragility (122). In addition, studies have shown that bone mass is 
positively related to body weight and BMI (123, 124), supporting our findings. However, the 
relative contribution of LM versus FM is controversial (123). 
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There are some limitations of our studies. In paper II and III all blood tests were drawn 
in the non-fasting state, and the levels of serum PTH and serum calcium could therefore have 
been influenced by calcium intake or smoking. In addition, the effect of sex steroids, intake of 
calcium and vitamin D were not assessed, all of which are known to be related to both BMD 
and body composition, as described in the introduction of this thesis. Adjustment for calcium- 
and vitamin D intake would probably have strengthened our studies. However, it is also 
known that calculation of dietary intake is prone to inaccuracy, as all variables based on 
questionnaires compiled on a recall basis are.  Further discussion on methodology is given in 
section 5.3. 
 
5.2 Body weight and vitamin D (Paper IV) 
We found, at baseline, an expected significant inverse association between serum 
levels of 25(OH)D and BMI, and a positive relation between serum PTH and body weight in 
this cohort of overweight and obese subjects, in accordance with other studies (10, 119). In 
support of our findings, a recent cross-sectional study in over 2000 subjects in Norway 
showed an inverse association between both 25(OH)D and 1,25(OH)2D levels and BMI (125).  
There were no significant differences between the groups in our study at baseline, and 
during the intervention period there was no significant weight change neither within any of 
the groups nor between the groups. Nor were there any significant change in percent FM or 
fat distribution, the latter evaluated by WHR. The expected reduction in serum PTH levels 
was observed, and there was an increase in the serum levels of 25(OH)D to the upper 
physiological range, which reached a plateau after three months and stabilized thereafter.  
Regarding the lack of effect of cholecalciferol on weight change, it should be kept in 
mind that there are several other factors which could influence our results, as for example 
compliance rate. However, the compliance rate was high in our study, 95% for the vitamin D 
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and placebo capsules, and for the calcium tablets ranging from 81% to 85%. Another 
possibility is that the choice of cholecalciferol was wrong, as other studies have shown 
significant weight reduction in obese subjects given alfa-calcidiol (126, 127).  However, in a 
study by Nilas et al., where they treated three different groups with either alfacalcidiol, 
cholecalciferol or calcitriol for one year, there was no significant effect on weight with either 
regimen (128). Nor did Trivedi et al. find any effect of cholecalciferol on body weight (129). 
Under normal physiological conditions, the level of 1,25(OH)2D is substrate dependent, i.e. 
the level of 1,25(OH)2D is dependent on the level of 25(OH)D (4, 23, 29). There are also 
conflicting results about the potency of ergocalciferol and cholecalciferol in humans (130, 
131).  Our rationale for selecting cholecalciferol was based on earlier findings concluding that 
cholecalciferol was more potent than ergocalciferol (4, 130). However, a recent paper by 
Holick et al. showed that ergocalciferol and cholecalciferol probably were equally effective in 
maintaining the serum level of 25(OH)D (131). 
 
It is also possible that the concomitant supplementation with calcium was a 
confounder in our study, as there are several studies regarding weight loss attributed to 
calcium supplementation (7, 8, 75, 120, 121). We cannot exclude that the calcium 
supplementation can have masked an effect of cholecalciferol on body weight. However, our 
subjects did not show any significant weight loss, and in studies with calcium 
supplementation in the order of our dosage (500 mg tablets) there are small effects on weight 
change compared to doses of double magnitude (121). Thus, we find it unlikely that the 
calcium supplementation has influenced our results to a significant degree. Adjustment for 
phosphate levels was not done, and hence could have changed our results. However, elevated 
serum concentrations of phosphate are relatively rare, and hence we do not believe that the 
lack of adjustment for phosphate have influenced our results.  
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It could also be that there actually is a “fat mass homeostasis”, and that sufficient 
levels of both calcium and vitamin D have to be present over time (i.e. years) in order to 
stabilize weight, and thus only one year of supplementation is too short a time period for 
weight change in overweight and obese subjects. This is supported by a recent placebo-
controlled study in postmenopausal women by Caan et al (132). They gave 400 IU 
cholecalciferol and 1000 mg elemental calcium daily for an average of seven years, and found 
a small effect on the prevention of weight gain.  
 
There is an ongoing debate regarding the optimal daily dosage of vitamin D, safety of 
vitamin D supplementation and the optimal serum concentration of vitamin D (30, 31, 133-
143). Most scientists with vitamin D as research field claim that today’s recommendations for 
daily vitamin D intake are too low. Our study gives an important contribution to this debate. 
The doses we used in our intervention study indicate that there is no danger of hypercalcemia 
or other serious adverse effects with doses of cholecalciferol several fold higher than the daily 
recommended dosage. However, obviously, results of a one-year intervention study in 334 
overweight and obese persons at our latitude cannot be extrapolated to prove safety for the 
general population worldwide.  
There are considerable strengths in this study as there were a high number of 
participants of both genders, and baseline and 12 months blood samples were collected in the 
fasting state and at the same time of day, as were also the DEXA-measurements. Our analyses 
are adjusted for age, gender, smoking status, calorie- , calcium and vitamin D intake, serum 





5.3 General aspects regarding methodology 
Selection bias could be a potential limitation of our studies. It is known that volunteers 
in population based surveys are often more interested in health issues, and hence they could 
represent a healthier population compared to non-participants. This implies that the results 
found probably are of weaker associations than they would have been if also non-participants 
had been studied. However, the attendance rates were high, and in the Tromsø Study the 
subjects were not selected because of any particular condition, and the incidence of 
cardiovascular diseases, mortality, education and lifestyle in Tromsø is not very different 
compared to other parts of Norway (144). The latitude of Tromsø at 70˚ N results in complete 
loss of sunshine during wintertime from late November until middle of January and no sunset 
from the middle of May until late July, thus giving considerable variation for the contribution 
of sunshine to vitamin D status. However, the population in the northern part of Norway has a 
relatively high intake of dietary vitamin D (32), which probably partly compensates for the 
lack of sunshine during winter. Thus, we find it unlikely that our study populations in paper I-
III are not representative for the general Norwegian population. In contrast, in paper IV, the 
participants had to be healthy overweight or obese persons, and thus the results from this 
study cannot be extrapolated to persons with lower BMI than 28.0 kg/m2 or to subjects 
suffering from major or serious illnesses. Even though the attendance rates in the Tromsø 
Studies were high, the attendance rates among the younger cohorts were lower, and hence the 
age distribution makes the results among younger men and premenopausal women more 
uncertain. In addition, practically all our participants in paper I-III were Caucasians, so our 
results cannot imply anything in subjects of other ethnic groups because of the known 
differences in body composition seen between people of different ethnicity.  
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Information bias is another possible limitation of our studies. It can be difficult to 
recall exactly the amount of ingested foods and the exact number of cigarettes smoked. 
Smokers tend to underestimate the number of cigarettes they smoke daily, and heavy drinkers 
tend to underestimate their amount of alcohol consumption. Regarding self reported physical 
activity, there are conflicting results of the validity of self reported physical activity level 
(145, 146). It seems as men, younger subjects and those with lower BMI tend to have more 
accurate estimations of physical activity compared to others (146). The accuracy of estimation 
of energy intake is also variable (147). Thus, the variables for cigarette smoking, physical 
activity, and nutrition and alcohol consumption are prone to some inaccuracy. Neither did we 
adjust for socioeconomic status, which affects body composition to a variable degree in both 
men and women (148, 149). 
 
BMD measured by DEXA gives only a two dimensional picture of bone, it gives no 
information of the histomorphometric structure (40, 41, 150). Thus, the impact of the various 
covariates on bone assessed in our studies is only attributable to the density, not the content or 
microstructure, of bone. The same holds for the forearm measurements by SXA. Regarding 
DEXA-measurements of body composition the accuracy seems to vary with age, gender and 
degree of overweight (151). Even though the precision of bone measurements and soft tissue 
is good, 1% and 2-3% respectively, the accuracy of the measurements is not well established, 
particularly regarding FM. In addition, DEXA cannot clearly distinguish bone from soft tissue 
in all body regions, and the scanner might not be big enough for larger persons (152). 
However, it is concluded in one recent study that DEXA measurements are valuable in 
longitudinal studies of changes in body composition (153). In the Tromsø Study the CV was 
only 0.9% for the SXA (paper II) and 1.7% for the DEXA measurements (paper II and III). 
Hence, the validity of the data for BMD was probably good.  
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The different ways of measuring body composition, differences in methodology and 
age distribution or ethnicity, implies that results and conclusions based on comparison with 
other studies using a different methodology must be interpreted with caution. BMI does not 
distinguish between FM and LM, and even though it is used for assessment of fatness it is 
almost as much a measure of leanness (152).  Both the degree of obesity and of underweight 
is often assessed by BMI (152). The BMI expression calculates the number of kilos of body 
weight divided by height squared. Thus, a person with proportionally higher MM than FM 
(e.g. a bodybuilder) can have the same BMI as an obese person with low MM but high FM. 
BMI is a better measure of fat content (kg) than fatness (%) (152). We find the use of our 
assessment methods for body composition satisfying and well rationalized, even though it 
would have been preferable to have DEXA measurements from the fourth Tromsø Study as 
well. 
 
It should also be emphasized that cross-sectional studies give only a moment in time- 
picture, which implies that causal relations from associations found cannot be drawn (paper II, 
partially paper I and III).  
 
However, all our studies also have considerable strength because of the large number 
of participants, the stratified analyses and the adjustment for several important possible 
confounders and effect modifiers. The longitudinal design in paper I and III and the 
intervention in IV further improve the strength of those studies. In addition, all measurements 






1. BMI is strongly related to smoking status and other lifestyle factors, as physical activity 
level, coffee- and alcohol consumption.  
2. The relation between number of cigarettes smoked daily and BMI is U-shaped. 
3. During a seven year period there was an increase in mean BMI in both men and women 
in all subgroups of smoking status, but smoking cessation was associated with an 
increase in body weight compared to those who continued smoking. 
4. There is a negative association between serum PTH and BMD at the hip in both men 
and women, and this relation seems to be diminished by smoking. 
5. Smoking reduces BMD at the hip, distal and ultradistal forearm in men, and the effect 
seems to be mainly time dependent and independent of dose.  
6. The negative effect of smoking on BMD diminishes after smoking cessation. 
7. Serum levels of PTH are positively associated with body FM in non-smokers. 
8. There might be a causal relation between PTH and body FM. 
9. Supplementation with high doses of cholecalciferol in conjunction with daily calcium 
supplementation over 12 months does not result in weight reduction in overweight and 
obese persons. 
10. Our results, in conjunction with the findings of others, demonstrates that body weight is 
determined by multiple factors, and hence it is not expected that one single variable, as 







7. Implications and further research  
The finding of a U-shaped relation between the number of cigarettes smoked daily and 
BMI implies that smokers are a heterogeneous group, and this has to be taken into 
consideration when the relation between BMI and smoking is being assessed. We have shown 
that smoking affects both serum PTH levels, BMD, BMI and the distribution of body fat, and 
these findings imply that adjustment for smoking status is mandatory whenever evaluating the 
relation between body composition and PTH. We have found a relation between change in 
PTH and change in BMI in non-smokers, and no effect of supplementation with 
cholecalciferol on weight in overweight and obese persons. Based on the results of the 
intervention study, we cannot recommend vitamin D supplementation as an aid for weight 
reduction.  
What is not known are the optimal levels of 25(OH)D regarding general health 
outcomes and the long-term safety of higher dosages than the current recommended intake of 
vitamin D. It is known that insufficient serum concentrations of vitamin D are associated with 
increased fall tendency (154) and fracture risk (155), reduced muscle function and strength 
(sarcopenia) (156), increased incidence and poorer outcomes of cardiovascular, pulmonary 
and immunological diseases and cancer (4, 30, 70), impaired mood and neuropshyciatric 
functions (157, 158). Vitamin D is also essential for brain development and function (159). 
Several reviews have also concluded that vitamin D supplementation may protect against 
development of diabetes mellitus and decrease total mortality rates (160, 161). Low 25(OH)D 
levels are associated with obesity, increased cardiovascular risk, hypertension, congestive 
heart failure and stroke (163). However, these are mainly associations and what are warranted 
are carefully conducted intervention studies to establish whether there is a cause-effect 
relationship or not. Before this is done, one should be careful recommending higher intakes of 
vitamin D than the current existing guidelines. 
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Thus, it is possible that sufficient serum levels of vitamin D and a normal calcium 
homeostasis are important in order to maintain normal body weight. As a final remark, 
regardless of whatever effect vitamin D may have on body composition, one pill is not 
enough: collaboration between the physician and the patient is essential for success, which is 
particularly true regarding weight reduction and smoking cessation. Some things in medicine 
have not changed since ancient times;  
 
“The art has three factors, the disease, the patient, the physician… The patient must 
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Appendix A. Questionnaires in the fourth Tromsø Study in 1994-1995 
1. First questionnaire, the Tromsø Study 1994-1995, Norwegian and English 
2. Second questionnaire, the Tromsø Study 1994-1995, for subjects below the age of 70, 
Norwegian and English 
3. Second questionnaire, the Tromsø Study 1994-1995, for subjects over the age of 70, 




















English translation of invitation with the first questionnaire used in the health 
survey in Tromsø 1994/95 
Translation based on translations by Kevin McCafferty and Anne Clancy
  
HEALTH SURVEY   
INVITATION 
 
"This is your chance" 
 
 
Date of birth  Social security No. 
 
Municipality  Electoral ward No. 
 
Welcome to the Tromsø 
Health Survey! 
 
The Health Survey is coming to Tromsø. 
This leaflet will tell you when and where. 
You will also find information about the 
survey in the enclosed brochure. 
 
We would like you to fill in the form overleaf 
and take it with you to the examination. 
 
The more people take part in the survey, 
the more valuable its results will be. We 
hope, therefore, that you will be able to 
come. Come along even if you feel 
healthy, if you are currently receiving 
medical treatment, or if you have had 
your cholesterol and blood pressure 
levels taken recently. 
 
Yours sincerely,  
Municipal Health Authorities  
Faculty of Medicine - University of Tromsø  
National Health Screening Service  
 
"This is a real opportunity — Take it!" 
 
Your own health 
 
What is your current state of health?  
Tick one box only. 
Poor  
Not so good  
Good  
Very good  
 
Do you have, or have you ever had:  
   YES  NO  Age first time 
Myocardial infarction   _____ years 
Angina pectoris    _____ years  
Stroke/   _____ years 
brain haemorrhage 
Asthma   _____ years  
Diabetes    _____ years  
 
Do you take medicine for high blood pressure? 
At the moment  
Used to, but not any longer  
Never have  
 
Have you during the last year suffered from pains 
and/or stiffness in muscles and joints that have lasted 
continuously for at least 3 months? 
    YES       NO    
 
Have you in the last two weeks felt: 
      No  A little     A lot  Very 
         much 
Nervous or worried?     
Anxious?      
Secure and calm?      
Irritable?      
Happy and optimistic?      
Down/depressed?      




Did any of the adults at home smoke while you were 
growing up?           YES       NO    
 
Do you now, or have you previously, lived with daily 
smokers after your 20th birthday?   
          YES       NO    
 
If "YES", for how many years in all? ____Years 
 
How many hours a day do you normally spend in 
smoke-filled rooms?         ________Hours 
Put 0 if you do not spend time in smoke-filled rooms. 
 
Do you yourself smoke:                 YES       NO 
Cigarettes daily?     
Cigars/cigarillos daily?     
Pipe daily ?      
 
If you previously smoked daily, how long is it since 
you stopped?               ______ Years 
 
If you smoke daily at the moment, or have smoked 
before: 
 
How many cigarettes do you smoke/did you 
smoke per day?     ______ Cigarettes 
 
How old were you when you began smoking 
daily?   Age   ______ Years 
 
How many years in all have you smoked 




How has your physical activity in leisure time been 
during this last year? Think of your weekly average for the 
year. Time spent going to work counts as leisure time. 
 
 Hours pr. week 
 None  Less than 1        1-2    3 or more 
Light activity                                   
 (not sweating or 
  out of breath) 
Hard activity                                    
(sweating/ 




How many cups of coffee do you drink daily? 
Put 0 if you do not drink coffee daily.        Cups 
  
Boiled coffee   
(i.e., grind boiled and allowed to draw) 




Are you a teetotaler?  YES       NO     
 
How many times a month do you normally drink 
alcohol? Do not count low-alcohol beer. ____ Times  
Put 0 if less than once a month. 
 
How many glasses of beer, wine or spirits do you 
normally drink in a fortnight? Do not count low-alcohol 
beer. Put 0 if less than once a month.   
Beer  Wine  Spirits 
Glasses  Glasses  Glasses 




What kind of margarine or butter do you normally use 
on bread? Tick one box only. 
Don't use butter/margarine      
Creamery butter      
Hard margarine      
Soft margarine      
Butter/margarine blend      




What is the highest level of education you have 
completed? 
 
7-10 years primary/secondary school,   
modern secondary school, 
 folk high school 
Technical school, middle school, vocational..  
school, 1-2 years' senior high school 
A-levels/High school diploma, (3-4 years)  
 
College/university, less than 4 years            
College/university, 4 or more years                
 
What is your current work situation? 
Paid work      
Full-time housework     
Education, military service    
Unemployed, redundant    
 
How many hours of paid work do you have pr. week?
              _____  Hours 
 
 
Do you receive any of the following benefits? 
Sickness benefit (sick leave)    
Rehabilitation benefit     
Disability pension     
Old-age pension     
Social welfare benefits     
Unemployment benefit    
 
Illness in the family 
 
Have one or more of your parents or siblings had a 
heart attack or had angina (heart cramp)? 
 
YES NO DON'T KNOW 






English translation of the second questionnaire used in the health survey in 
Tromsø 1994/95 for subjects younger than 70 years. 
Based on translations by K. McCafferty and A. Clancy 
 
TROMSØ HEALTH SURVEY 
 
 The main aim of the Tromsø survey is to improve 
our knowledge of heart and circulatory conditions in order 
to aid prevention. The survey is also intended to improve 
our knowledge of cancer and other general conditions, such 
as allergies, muscle pains and nervous conditions. We 
would therefore like you to answer some questions about 
factors that may be relevant for your risk of getting these 
and other illnesses. 
 
 
 This form is part of the Health Survey, which has 
been approved by the Norwegian Data Inspectorate and 
the Regional Board of Research Ethics. The answers will 
only be used for research purposes and will be treated in 
strict confidence. The information you give us may later be 
stored along with information from other public health 
registers in accordance with the rules laid down by the 
Data Inspectorate and the Regional Board of Research 
Ethics. 
 
 If you are unsure about what to answer, tick the 
box that you feel fits best. 
 
 The completed form should be sent to us in the 
enclosed pre-paid envelope.  
 




Faculty of Medicine  National Health 
University of Tromsø Screening Service 
 
If you do not wish to answer the questionnaire, tick the box 
below and return the form. Then you will not receive 
reminders. 
 




Date for filling in this form: Day/Month/Year 
 
CHILDHOOD/YOUTH 
What Norwegian municipality did you live in at the age of 
1 year?  ___________________________________________ 
 
If you did not live in Norway, give country of residence instead of 
municipality. 
 
How was your family's economic situation while you were 
growing up? 
Very good  
Good  
Difficult  
Very difficult  
 
For how much of the first three years of your life  
- did you live in a town/city? ____ Years 
- did your family have a cat or dog in the home?  
  ____ Years 
 
For how much of the first 15 years of your life 
- did you live in a town/city? ____ Years 
- did your family have a cat or dog in the home?
  ____ Years 
HOME 
Who do you live with? 
Tick once for each item and give the number of persons. 
 YES     NO   Number 
Spouse/partner             _____ 
Other persons over 18 years             _____ 
Persons under 18 years             _____ 
 
How many of the children go to day care/kindergarten/ 
nursery school?    ____ 
 
What type of home do you live in? 
Villa/ detached house   
Farm  
Flat /Apartment   
Terraced /semi-detached house   
Other   
 
How big is your home?   _____ m2 
 
Approximately what year was your home built? ______ 
  YES NO 
Has your home been insulated after 1970?   
Do you live on the bottom floor/cellar level?   
If "YES", is the floor laid on concrete?   
 
 
What is the main source of heat in your home? 
Electric heating   
Wood-burning stove   
Central heating system using:  
Paraffin   
Electricity   
 
Do you have fitted carpets in the  YES  NO  
living-room?        
 
Is there a cat in your home?       
Is there a dog in your home?       
 
WORK 
If you are in paid or unpaid work, which statement 
describes your work best? 
I am mainly seated while working   
(e.g., at a desk/assembly work) 
My work requires a lot of walking   
(e.g., shop assistant, light industrial work, teaching) 
My work entails a lot of walking and lifting  
(e.g., postman/woman, nurse, building work) 
I do heavy physical work    
(e.g., forestry, heavy agricultural/construction work) 
 
Do you have any influence on how your work is organised? 
No, not at all      
To a small extent     
Yes, to a large extent     
Yes, I decide myself     
 
Are you on call; do you  YES NO 
work shifts or nights?   
 
Do you do any of the following jobs (full- or part-time)?  
Tick one box only for each item. YES NO 
Driver   
Farmer   
Fisherman   
 
YOUR OWN ILLNESSES 
Have you ever had: 
Tick one box only for each item. Give your age at the time. 
If you have had the condition several times, how old were you 
last time? 
 YES NO  AGE 
Hip fracture   _____ 
Wrist/forearm fracture   _____ 
Whiplash   _____ 
Injury requiring   _____ 
hospital admission 
Stomach ulcer   _____ 
Duodenal ulcer   _____ 
An operation for stomach/ 
duodenal ulcer   _____ 
Throat/ neck operation   _____ 
 
Have you you ever had, or do you still have: 
Tick one box only for each item. YES NO 
Cancer   
Epilepsy   
Migraine   
Chronic bronchitis   
Psoriasis   
Osteoporosis   
Fibromyalgia/fibrositis/ 
chronic pain syndrome   
Psychological problems for which 
you have sought help   
Thyroid disease   
Liver disease   
Kidney stone   
Appendectomy   
Allergy and hypersensitivity: 
Atopic eczema (e.g., childhood eczema)   
Hand eczema   
Hay fever   
Food allergy   
Other hypersensitivity (not allergy)   
 
How many times have you had a cold, influenza (flue), 
vomiting/diarrhoea, or similar in the last six months?
     ______ times 
Have you had any of these in the last two weeks? 
    YES NO 
   
 
ILLNESS IN THE FAMILY 
Tick the appropriate box for relatives that have, or have 
ever had the following illnesses: Tick "None" if none of your 
relatives have had the condition. 
 
 Mother  Father  Brother  Sister  Child  None 
Stroke or brain 
haemorrhage       
Myocardial infarction 
before age 60        
Cancer       
Asthma       
Stomach/ 
duodenal ulcer       
Osteoporosis       
Psychological 
problems       
Allergy       
Diabetes       
-age when they 





Do you cough approximately every day      YES NO 
of the year?       
If "Yes": Is your cough productive ?       
Have you had this kind of cough for as long 
as 3 months in each of the last two years?       
 
Have you had periods of wheezing 
in your chest?    
If "Yes", has this occurred: 
Tick one box only for each item. 
At night    
In connection with respiratory infections   
In connection with physical exertion   
In connection with very cold weather   
 
Have you noticed sudden changes in your pulse 
or heart rhythm in the last year?   
 
How often do you suffer from sleeplessness? 
Never, or just a few times a year   
1-2 times a month   
Approximately once a week   
More than once a week   
 
If you suffer from periods of sleeplessness, what times of 
the year does it affect you most? 
No particular time of year     
Especially during the dark winter months   
Especially during the midnight sun period   
Especially in spring and autumn    
 
Have you in the last twelve months suffered from 
sleeplessness to the extent that it has affected your ability to 
work?    YES   NO   
 
How often do you suffer from headaches? 
Seldom/Never      
Once a month or more    
Once a week or more      
Every day       
 
Does the thought of getting a serious illness ever worry 
you? 
Not at all      
Only a little      
Some      
Very much      
 
 
USE OF HEALTH SERVICES  
How many visits have you made during the past year due 
to your own health or illness?Tick 0 if you have not had such 
contact Number of times 
  the past year 
To a general practitioner (GP)/ 
Emergency GP       _____ 
Psychologist or psychiatrist      _____ 
Other medical specialist (not at a hospital)  _____ 
Hospital out-patient clinic      _____ 
Hospital admission       _____ 
Medical officer at work         _____ 
Physiotherapist       _____ 
Chiropractor        _____ 
Acupuncturist        _____ 
Dentist        _____ 
Alternative medical practitioner 
(homoeopath, foot zone therapist, etc.)      _____ 
Healer, Faith healer, clairvoyant     _____ 
 
MEDICATION AND DIETARY SUPPLEMENTS 
Have you for any length of time in the past year used any 
of the following medicines every day or almost daily? 
Indicate how many months you used them for.    
Write 0 for items you have not used. 
Medication: 
Painkillers    _____ mths 
Sleeping pills    _____ mths 
Tranquilizers    _____ mths 
Antidepressants   _____ mths 
Allergy drugs    _____ mths 
Asthma drugs   _____ mths 
Dietary supplements 
Iron tablets    _____ mths 
Calcium tablets or bonemeal  _____ mths 
Vitamin D supplement   _____ mths 
Other vitamin supplements  _____ mths 
Cod liver oil or fish oil capsules  _____ mths 
 
Have you in the last 14 days used the following medicines 
or dietary supplements? 
Tick one box only for each item. 
Medicines    YES NO 
Painkillers            
Antipyretic drugs (to reduce fever)          
Migraine drugs           
Eczema cream/ointment            
Heart medicine (not blood pressure)          
Lipid lowering drugs           
Sleeping pills            
Tranquilizers            
Antidepressants           
Other drugs for nervous conditions          
Antacids            
Gastric ulcer drugs           
Insulin            
Diabetes tablets           
Thyroxin tablets (for metabolic disorder)-       
Cortisone tablets           
Other medicine(s)            
 
Dietary supplements   YES NO 
Iron tablets            
Calcium tablets or bonemeal          
Vitamin D supplement           
Other vitamin supplements          





How many good friends do you have whom you can talk 
confidentially with and who give you help when you need 
it?    ______ good friends 
Do not count people you live with, but do include other relatives! 
 
How many of these good friends do you have contact with 
at least once a month?  ______ 
 
Do you feel you have enough good friends? YES     NO   
 
How often do you normally take part in organised 
gatherings, e.g., sewing circles, sports clubs, political 
meetings, religious or other associations? 
Never, or just a few times a year   
1-2 times a month     
Approximately once a week    
More than once a week    
 
DIET 
If you use butter or margarine on your bread, how many 
slices does a small catering portion normally cover? By this, 
we mean the portion packs served on planes, in cafés, etc. 
(i.e., 10-12g) 
 
A catering portion is enough for about  ____  slices. 
 
What kind of fat is normally used in cooking (not on the 
bread) in your home? 
Creamery butter     
Hard margarine     
Soft margarine     
Butter/margarine blend    
Oils       
 
What kind of bread (bought or home-made) do you usually 
eat? Tick one or two boxes! 
The bread I eat is most similar to 
White bread        
Light textured brown bread    
Ordinary brown bread     
Coarse brown bread      
Crisp bread      
 
How much (in number of glasses, cups, potatoes or slices) 
do you usually eat or drink daily of the following 
foodstuffs? Tick one box for each foodstuff. 
  Less    More  
 0 than 1 1-2 3-4 5-6 than 6 
Full cream milk    
(fresh or soured) (glasses)       
Semi-skimmed milk (low-fat) 
(fresh or soured) (glasses)        
Skimmed milk (fresh or soured)   
(glasses)       
Tea (cups)        
Orange juice (glasses)        
Potatoes       
Slices of bread in total 
(incl. crispbread)        
  Less    More  
 0 than 1 1-2 3-4 5-6 than 6 
Slices of bread with fish  
(e.g., mackerel in tomato sauce       
- lean meat (e.g., ham)        
- fat meat (e.g., salami)        
- cheese (e.g. Gouda/ Norvegia)       
- brown cheese       
- smoked cod caviar       
- jam and other sweet spreads        
 
How many times per week do you normally eat the 
following foodstuffs?  Tick a box for all foodstuffs listed. 
          Less            Roughly 
             Never  than 1   1 2-3 4-5 every day 
Yoghurt                                      
Boiled or fried egg                                    
Breakfast cereal/ 
oat meal, etc.                                      
For dinner  
- meat                                      
- sausage/meatloaf/ 
meatballs                                     
- fat fish (e.g., salmon/ 
redfish)                                     
- lean fish (e.g., cod) 
- fishballs/fishpudding/ 
fishcakes                                     
- vegetables                                     
Mayonnaise, remoulade                                     
Carrots                                      
Cauliflower/cabbage/ 
broccoli                                      
Apples/pears                                     
Oranges, mandarines                                     
Sweetened soft drinks                                    
Sugarfree ("Light")  
soft drinks                                     
Chocolate                                     




How often do you usually drink beer? wine?  spirits? 
Never, or just a few times a year                             
1-2 times a month                              
Roughly once a week                              
2-3 times a week                              
Roughly every day                              
 
Approximately how often in the last year have you drunk 
alcohol that equals at least 5 small bottles of beer, a bottle of 
wine, or 1/4 bottle of spirits? 
Not in the last year     
Just a few times     
1-2 times a month     
1-2 times a week     
3 or more times a week    
 
For approximately how many years has your alcohol 




About how many times have you deliberately tried to lose 
weight? Write 0 if you never have. 
- before age 20   _____ times 
- after age 20   _____ times 
 
If you have lost weight, about how many kilos have you 
ever lost at the most? 
- before age 20 _____ times _____ kg 
- after age 20 _____ times _____ kg 
 
What weight would you be satisfied with (your "ideal 
weight")?    _____ kg 
 
URINARY INCONTINENCE 
How often do you suffer from urinary incontinence? 
Never      
Not more than once a month    
Two or more times a month    




































Thank you for helping us! Remember to post the 
form today! 
Tromsø Health Survey 
 
TO BE ANSWERED BY WOMEN ONLY 
MENSTRUATION 
How old were you when you had your first menstruation?
     _____ years 
If you no longer menstruate, how old were you when you 
stopped having menstruation?  _____ years 
 
Apart from pregnancy and after giving birth, have you ever 
stopped having menstruation for 6 months or more? 
    YES NO   
      
If "Yes", how many times?  _____ times 
 
If you still menstruate or are pregnant: 
What date did your last menstruation begin?
 day/month/year  ___ / ___ / ___ 
Do you normally use painkillers to relieve period pains?
    YES   NO   
 
PREGNANCY 
How many children have you  
given birth to?   _____ children 
 
Are you pregnant at the moment?  YES NO Don’t know 
    
During pregnancy, have you had high blood pressure 
and/or proteinuria?  YES   NO   
If "Yes", during which pregnancy?  Pregnancy 
          First Later 
High blood pressure                  
Proteinuria                    
 
If you have given birth, fill out for each child the year of 
birth and approximately how many months you breastfed 
the child. 
Child: Year of birth: Number of months breastfed: 
 
1 ___________  ______ months 
2 ___________  ______ months 
3 ___________  ______ months 
4 ___________  ______ months 
5 ___________  ______ months 
6 ___________  ______ months 
 
CONTRACEPTION AND OESTROGEN 
Do you, or have you ever, used:  Now Used to  Never: 
Contraceptive pills (incl.minipill)      
A hormonal intrauterine device      
Oestrogen (tablets or patches)      
Oestrogen (cream or suppositories)      
 
If you use contraceptive pills, hormonal intrauterine device, 
or oestrogen, what brand do you currently use?   
 ________________________________________ 
If you use, or have ever used, contraceptive pills: 
Age when you began taking the pill?       _____years 
How many years in total have you taken the pill? 
         _____years 
If you have given birth, how many years did you take 
the pill before your first child?      _____years 
If you have stopped taking the pill: 






English translation of the second questionnaire used in the health survey in 
Tromsø 1994/95 for subjects 70 years or older. 
Based on translations by Kevin McCafferty and Anne Clancy. 
 
TROMSØ HEALTH SURVEY 
for the over 70s 
 
 The main aim of the Tromsø survey is to improve 
our knowledge of heart and circulatory conditions in order 
to aid prevention. The survey is also intended to improve 
our knowledge of cancer and other general conditions, such 
as allergies, muscle pains and nervous conditions. The 
ultimate aim is to gain an overview of the general health of 
the elderly population. We would therefore like you to 
answer the questions below.  
 
 This form is part of the Health Survey, which has 
been approved by the Norwegian Data Inspectorate and the 
Regional Board of Research Ethics. The answers will only be 
used for research purposes and will be treated in strict 
confidence. The information you give us may later be stored 
along with information from other public health registers in 
accordance with the rules laid down by the Data 
Inspectorate and the Regional Board of Research Ethics. 
 
 If you are unsure about what to answer, tick the 
box that you feel fits best. 
 
 The completed form should be sent to us in the 
enclosed pre-paid envelope.  
 




Faculty of Medicine  National Health 
University of Tromsø Screening Service 
 
If you do not wish to answer the questionnaire, tick the box 
below and return the form. Then you will not receive 
reminders. 
 
I do not wish to answer the questionnaire.   
 
 




What Norwegian municipality did you live in at the age of 1 
year? 
 
If you did not live in Norway, give country instead of 
municipality. 
 
How was your family's financial situation while you were 
growing up? 
Very good      
Good       
Difficult      
Very difficult      
How old were your parents when they died? 
Mother   ______ years 
Father    ______ years 
HOME 
 
Who do you live with? 
Tick one box for each item and give the number of persons.  
YES     NO   Number 
Spouse/partner                      
Other persons over 18 years                    _______ 
Persons under 18 years                     _______ 
 
What type of home do you live in? 
Villa/detached house     
Farm       
Apartment/flat in block/terrace     
Terraced/semi-detached house    
Other       
 
How long have you lived in your present home? ____years 
 
Is your home adapted to your needs? YES   NO   
If "No", do you have problems with: 
Space       
Variable temperature/too cold/too warm   
Stairs       
Toilet       
Bath/shower      
Maintenance      
Other (please specify)     
 
Would you like to move into a retirement home? 
     YES   NO   
 
PREVIOUS WORK AND FINANCIAL SITUATION 
 
Which statement best describes the type of work you did for 
the last 5-10 years before you retired? 
 
I was mainly seated while working   
(e.g., desk/assembly work) 
My work required a lot of walking   
(e.g., shop assistant, housewife, teaching) 
My work required a lot of walking and lifting  
(e.g., postman, nurse, construction work) 
I did heavy physical work    
(e.g., forestry, heavy agricultural work, 
 heavy construction work) 
 
Did you do any of the following jobs (full- or part-time)?  
Tick one box only for each item.  YES NO 
Driver            
Farmer           
Fisherman           
 
How old were you when you retired? ______ years 
 
What kind of pension do you have? 
Basic state pension     
Additional pension     
How is your current financial situation? 
Very good      
Good       
Difficult      
Very difficult      
 
HEALTH AND ILLNESS 
Has your state of health changed in the last year? 
Yes, it has got worse     
No, unchanged      
Yes, it has got better     
 
How do you feel your health is now compared to others of 
your age? 
Much worse      
A little worse      
About the same      
A little better      
Much better      
 
YOUR OWN ILLNESSES 
 
Have you ever had: 
Tick one box only for each item. Give your age at the time. If you 
have had the condition several times, how old were you last time?  
    YES NO  AGE 
Hip fracture             _____ 
Wrist /forearm fracture           _____ 
Whiplash            _____ 
Injury requiring            _____ 
hospital admission 
Stomach ulcer            _____ 
Duodenal ulcer            _____ 
Stomach/duodenal  
ulcer operation            _____ 
Throat/neck surgery           _____ 
 
Have you ever had, or do you still have: 
Tick one box only for each item.  YES NO 
Cancer          
Epilepsy          
Migraine          
Chronic bronchitis         
Psoriasis          
Osteoporosis          
Fibromyalgia/fibrositis/ 
chronic pain syndrom         
Psychological problems for which 
you have sought help         
Thyroid disease         
Liver disease          
Thyroid disease         
Liver disease          
Recurrent urinary incontinence        
Glaucoma          
Cataract          
Arthrosis (osteoarthritis)        
Rheumatoid arthritis          
Kidney stone          
Appendectomy         
Allergy and hypersensitivity   
   Atopic eczema (e.g., childhood eczema)               
   Hand eczema         
   Hay fever          
   Food allergy         
  Other hypersensitivity (not allergy)       
 
How many times have you had a cold, influenza (flue), 
diarrhea/vomiting, or similar in the last six months?  
        ______ times  
Have you had any of these in the last two weeks? 
     YES   NO   
ILLNESS IN THE FAMILY 
Tick off relatives who have, or have ever had, any of the 
following conditions: 
Tick "None" for conditions which none of your relatives have had.  
              Mother Father Brother Sister Child None 
 
Stroke or brain  
haemorrhage                              
Myocardial infarction 
before age 60                               
Cancer                               
Hypertension                              
Asthma                               
Osteoporosis                          
Arthrosis  
(osteoarthritis)                          
Psychological 
problems                          
Dementia                          
Diabetes                              
-age when they 
got diabetes        ___          ___          ___   ___    ___     ___ 
 
SYMPTOMS 
Do you cough daily for periods of the year?    YES   NO 
              
If "Yes": 
Is your cough productive?           
 
Have you had this kind of cough for as long 
as 3 months in each of the last two years?        
 
Have you had periods of wheezing 
in your chest?             
If "Yes", has this occurred: 
Tick one box only for each item. 
At night             
In connection with respiratory infections         
In connection with physical exertion          
In connection with very cold weather          
 
Have you noticed sudden changes in your pulse 
or heart rhythm in the last year?            
 
Have you lost weight in the last year?               
If "Yes": 
How many kilograms?  ______ kg 
 
How often do you suffer from sleeplessness? 
Never, or just a few times a year   
1-2 times a month     
Approximately once a week    
More than once a week    
 
If you suffer from periods of sleeplessness, what times of 
the year does it affect you most? 
No particular time of year    
Especially during the 'dark winter months'  
Especially during the midnight sun period  
Especially in spring and autumn    
Do you usually take a nap during the day?  YES   NO   
 
Do you feel that you normally get enough sleep? YES   NO   
 
No A little A lot 
Do you suffer from:                
Dizziness                 
Poor memory                 
Lack of energy                 
Constipation                 
 
Does the thought of getting a serious illness ever  
worry you? 
Not at all         
Only a little         
Some          
Very much         
 
BODILY FUNCTIONS 
Can you manage the following everyday activities on your 
own without help from others? 
Yes     With some  No 
 help 
Walking indoors on one level               
Walking up/down stairs                 
Walking outdoors                
Walking approx. 500 metres               
Going to the toilet                
Washing yourself                
Taking a bath/shower                
Dressing and undressing               
Getting in and out of bed               
Eating meals                 
Cooking                            
Doing light housework                
(e.g., washing up) 
Doing heavier housework               
(e.g., cleaning floors) 
Going shopping                
Taking the bus                             
 
Yes    With      No  
              difficulty    
Can you hear normal speech               
(if necessary with a hearing aid)? 
Can you read                 
(if necessary with glasses)? 
 
Are you dependent on any of the following aids? 
     Yes  No 
Walking stick          
Crutches          
Walking frame/Zimmer frame        
Wheelchair          
Hearing aid          
Safety alarm device         
 
USE OF HEALTH SERVICES 
How many visits have you made during the past year due 
to your own health or illness: 
Tick 0 if you have not had such contact 
     Number of times the past year 
  
To a general practitioner (GP)/ 
emergency GP     _____ 
Psychologist or psychiatrist   _____ 
Other medical specialist (not at a hospital)  _____ 
Hospital out-patient clinic   _____ 
Hospital admission     _____ 
Physiotherapist     _____ 
Chiropractor     _____ 
Acupuncturist     _____ 
Dentist     _____ 
Chiropodist     _____ 
Alternative medical practitioner  
(homoeopath, foot zone therapist, etc.)   _____ 
Healer, Faith healer, clairvoyant    _____ 
 
Do you have domestic help? Yes  No 
Private     
Municipal     
Do you receive services from the district nurse?     
 
Are you pleased with the health care and home assistance 
services your municipality supplies? 
Yes No Don't know 
Assigned family GP                   
District nurse                   
Home assistance                  
 
Do you feel confident that you can receive the health care 
and home assistance you require if you need it? 
Confident      
Not confident      
Very unsure      
Don't know      
 
MEDICATION AND DIETARY SUPPLEMENTS 
Have you for any length of time in the past year used any of 
the following medicines every day or almost daily? 
Indicate how many months you used them for. 
Write 0 for items you have not used. 
Medication: 
Painkillers   ______ mths 
Sleeping pills   ______ mths 
Tranquillizers   ______ mths 
Antidepressants   ______ mths 
Allergy drugs   ______ mths 
Asthma drugs   ______ mths 
Heart medicine (not blood pressure)    ______ mths 
Insulin    ______ mths  
Diabetes tablets   ______ mths  
Thyroxin tablets  
(for metabolic disorder)  ______ mths  
Cortisone tablets   ______ mths  
Remedies for constipation  ______ mths  
Dietary supplements: 
Iron tablets   ______ mths 
Vitamin D supplement  ______ mths 
Other vitamin supplements ______ mths 
Calcium tablets or bonemeal ______ mths 
Cod liver oil or fish oil capsules ______ mths 
 
FAMILY AND FRIENDS 
Do you have close relatives who can give you help and 
support when you need it?  Yes    No   
If "Yes", who can give you help? 
Spouse/partner   
Children     
Others      
How many good friends do you have whom you can talk 
confidentially with and who give you help when you need it?
    _______good friends 
Do not count people you live with, but do include other relatives! 
 
Do you feel you have enough good friends? Yes    No  
Do you feel that you belong to a community or group of 
people who can depend on each other and who feel 
committed to each other (e.g., a political party, religious 
group, relatives, neighbours, work place, or organisation)? 
Strong sense of belonging    
Some sense of belonging     
Not sure      
Little or no sense of belonging    
 
How often do you normally take part in organised 
gatherings, e.g., sewing circles, sports clubs, political 
meetings, religious or other associations? 
Never, or just a few times a year    
1-2 times a month     
Approximately once a week    
More than once a week     
 
DIET 
How many meals a day do you normally eat (dinner and 
smaller meals)?    _____ Number 
 
How many times a week do you eat a hot dinner?  
     _____ Number 
 
What kind of bread (bought or home-made) do you usually 
eat? Tick one or two boxes! 
 
The bread I eat is most similar to 
White bread       
Light textured brown bread       
Ordinary brown bread       
Coarse brown bread        
Crisp bread        
 
What kind of fat is normally used in cooking (not on the 
bread) in your home? 
Creamery butter     
Hard margarine     
Soft margarine      
Butter/margarine blend     
Oils        
How much (in number of glasses, cups, potatoes or slices) 
do you usually eat or drink daily of the following 
foodstuffs? Tick one box for each foodstuff. 
 Less 
                0 than 1  1-2  3-4  5-6  6- 
Milk of all types (glasses)                                          
Orange juice (glasses)                                           
Potatoes                                            
Slices of bread in total  
(incl. crispbread)                                           
Slices of bread with fish  
(e.g., mackerel in tomato sauce)                                
- cheese (e.g., Norwegia)                                            
- smoked cod caviar                                          
How many times per week do you normally eat the 
following foodstuffs?  Tick a box for all foodstuffs listed. 
         Less            Roughly 
             Never  than 1  1    2-3  4-5  every day 
Yoghurt                                       
Boiled or fried egg                                     
Breakfast cereal/ 
oat meal, etc.                                       
For dinner  
- meat                                       
- fat fish (e.g., salmon/ 
redfish)                                      
- lean fish (e.g., cod) 
- vegetables (raw or cooked)                                    
Carrots (raw or cooked)                                      
Cauliflower/cabbage/broccoli                                     
Apples/pears                                       




How content do you generally feel with growing old? 
Good         
Quite good        
Up and down        
Bad          
What is your view of the future? 
Bright         
Not too bad        
Quite worried        




TO BE ANSWERED BY WOMEN ONLY  
MENSTRUATION 
How old were you when you had your first menstruation?
     _____ years  
How old were you when you stopped having 
menstruations?    _____ years 
 
PREGNANCY 
How many children have you given birth to?                             
     _____children  
If you have given birth, fill out for each child the year of 
birth and approximately how many months you breastfed 
the child. If you have given birth to more than 6 children, 
note their birthyear and number of months you breastfed at 
the space provided below for comments.   
Child: Year of birth: Number of months breastfed: 
 
1 ___________ _____________ months 
2 ___________ _____________ months 
3 ___________ _____________ months 
4 ___________ _____________ months 
5 ___________ _____________ months 
6 ___________ _____________ months  
During pregnancy, have you had high blood pressure 
and/or proteinuria?   Yes    No    
If "Yes", during which pregnancy?  
    Pregnancy 
  First Later 
High blood pressure          
Proteinuria           
 
OESTROGEN 
Do you, or have you ever used oestrogen: 
    Now Used to   Never 
Tablets or patches                    
Cream or suppositories                    
 





Thank you for helping us! Remember to post the form 
today!  Tromsø Health Survey 
 
Appendix B. Questionnaires in the fifth Tromsø Study in 2001-2002  
1. Questionnaire, the Tromsø Study 2001-2002, for subjects below the age of 70, 
Norwegian  
2. Questionnaire, the Tromsø Study 2001-2002, for subjects over the age of 70, Norwegian  





















Medisin mot høyt blodtrykk ..........................
Kolesterolsenkende medisin ........................
Leser, ser på fjernsyn eller annen
stillesittende beskjeftigelse?.................................................
Spaserer, sykler eller beveger deg på 
annen måte minst 4 timer i uka?..........................................
(Her skal du også regne med gang eller 
sykling til arbeidsstedet, søndagsturer m.m.)
Driver mosjonsidrett, tyngre hagearbeid e.l.? ......................
(Merk at aktiviteten skal vare minst 4 timer i uka)
Trener hardt eller driver konkurranseidrett 
regelmessig og flere ganger i uka?......................................
Ingen Under 1 1-2 3 og mer
10.1 Hvordan har din fysiske aktivitet i fritiden vært 
det siste året?
Tenk deg et ukentlig gjennomsnitt for året.
Arbeidsvei regnes som fritid. Besvar begge spørsmålene.
11.3 Hvor stor interesse viser folk for det du gjør?
(Sett bare ett kryss)
11.4 Hvor mange foreninger, lag, grupper,
kirkesamfunn e.l. deltar du i på fritiden?         Antall
(Skriv 0 hvis ingen)
11.5 Føler du at du kan påvirke det som skjer i 
lokalsamfunnet der du bor? (Sett bare ett kryss)
12.1 Har en eller flere av dine foreldre eller søsken 
hatt hjerteinfarkt (sår på hjertet) eller
angina pectoris (hjertekrampe)? ........................
12.2 Kryss av for de slektningene som har eller har
hatt noen av sykdommene: (Sett kryss for hver linje)
Hjerneslag eller
hjerneblødning.............





12.3 Hvis noen slektninger har diabetes, i hvilken alder fikk de
diabetes (hvis for eks. flere søsken, før opp den som fikk det 
tidligst i livet):
11.2 Hvor mange gode venner har du? Antall venner
Regn med de du kan snakke fortrolig med
og som kan gi deg hjelp dersom du trenger det.
Tell ikke med de du bor sammen med, men 
ta med andre slektninger.
10.2 Angi bevegelse og kroppslig anstrengelse i din fritid. Hvis
aktiviteten varierer meget f.eks. mellom sommer og vinter, så
ta et gjennomsnitt. Spørsmålet gjelder bare det siste året.
(Sett kryss i den ruta som passer best)
1 2 3 4
10. MOSJON OG FYSISK AKTIVITET
11. FAMILIE OG VENNER
12. SYKDOM I FAMILIEN
13. BRUK AV MEDISINER
14. RESTEN AV SKJEMAET SKAL BARE
BESVARES AV KVINNER
13.1 Bruker du?
14.1 Hvor gammel var du da du fikk 
menstruasjon aller første gang? Alder i år
14.2 Hvis du ikke lenger får menstruasjon,
hvor gammel var du da den sluttet? Alder i år
14.3 Er du gravid nå?
14.4 Hvor mange barn har du født? Antall barn
14.5 Bruker du, eller har du brukt?
(Sett ett kryss for hver linje)
13.2 Hvor ofte har du i løpet av de siste 4 ukene brukt
følgende medisiner?
(Sett ett kryss pr. linje)
13.3 For de medisinene som du har krysset av for i pkt. 13.1 og 13.2,























Mors alder Fars alder Brors alder Søsters alder Barns alder
Far Bror Søster Barn
Ingen
av disse
Ja, en del Ja, i liten grad Nei
Har ikke
forsøkt




Med medisiner mener vi her medisiner kjøpt på apotek.





Medisin mot depresjon .............
Annen medisin på resept..........
P-pille/minipille/p-sprøyte............
Hormonspiral (ikke vanlig spiral)
Østrogen (tabletter eller plaster)
Østrogen (krem eller stikkpiller)
Angi navnet og hvilken grunn det er til at du tar/har tatt
disse (sykdom eller symptom):











Navn på medisinen: Grunn til bruk Inntil Ett år
(ett navn pr. linje): av medisinen: 1 år eller mer
Dersom det ikke er nok plass her, kan du fortsette på eget ark som du legger ved.


































Før, men ikke nå Aldri
14.6 Hvis du bruker/har brukt reseptpliktig østrogen:
Hvor lenge har du brukt dette? Antall år
14.7 Hvis du bruker p-pille, minipille, p-sprøyte,
hormonspiral eller østrogen; hvilket merke bruker du?
Personlig innbydelse
Ikke skriv her:
1 2 3 4
Helse- 
undersøkelsen
5.3 (Kommune) (Fylke) (Land)
9.3 (Virksomhet) 9.4 (Yrke) 14.7 (Merke)
1 2 3 4 5
11.1 Bor du sammen med:
Ektefelle/samboer? ......................................
NEIJA











2.1 Har du vært plaget med smerter og/eller stivhet 
i muskler og ledd i løpet av de siste 4 ukene?
(Varighet angis bare hvis du har hatt plager)
5.1 Hvor lenge har du samlet bodd i fylket?
(Sett 0 hvis mindre enn et halvt år)
5.2 Hvor lenge har du samlet bodd i kommunen?
(Sett 0 hvis mindre enn et halvt år)
5.3 Hvor bodde du det meste av tiden før du fylte 16 år?




Annet fylke i Norge .... Hvilket:
Utenfor Norge ............ Land:
5.4 Har du flyttet i løpet av de siste fem årene?
Nei Ja, en gang Ja, flere ganger
1 2 3
NEIJA
1.1 Hvordan er helsen din nå? (Sett bare ett kryss)
Dårlig Ikke helt god God Svært god
1 2 3 4
1.4 Får du smerter eller ubehag i brystet når du:
Går i bakker, trapper eller fort på flat mark?.................
1.6 Dersom du stopper, forsvinner smertene da
etter mindre enn 10 minutter? ...................................
1.7 Kan slike smerter opptre selv om du er i ro? ..........
1.5 Hvis du får slike smerter, pleier du da å:










Øvre del av ryggen ...
Korsryggen................
Hofter, ben, føtter ......
Andre steder..............











2.2 Har du noen gang hatt:
Brudd i håndledd/underarm? .....................
Lårhalsbrudd? ............................................
1. EGEN HELSE 3. ANDRE PLAGER 7. MAT OG DRIKKE 8. RØYKING
9. UTDANNING OG ARBEID
4. BRUK AV HELSETJENESTER
5. OPPVEKST OG TILHØRIGHET
6. VEKT
2. MUSKEL OG SKJELETTPLAGER
3.1 Under finner du en liste over ulike problemer. Har du opplevd 
noe av dette den siste uken (til og med i dag)?
(Sett ett kryss for hver plage)
Plutselig frykt uten grunn..........................
Føler deg redd eller engstelig...................
Matthet eller svimmelhet ..........................
Føler deg anspent eller oppjaget..............
Lett for å klandre deg selv........................
Søvnproblemer .........................................
Nedtrykt, tungsindig..................................
Følelse av å være unyttig, lite verd ..........
Følelse av at alt er et slit ..........................









1 2 3 4
7.1 Hvor ofte spiser du vanligvis disse matvarene?
(Sett ett kryss pr. linje)
7.2 Hva slags fett bruker du oftest? (Sett ett kryss pr. linje)
7.3 Bruker du følgende kosttilskudd:
8.1 Hvor lenge er du vanligvis daglig 
tilstede i røykfylt rom? Antall hele timer
8.2 Røykte noen av de voksne hjemme 
da du vokste opp?.................................................
8.3 Bor du, eller har du bodd, sammen med 
noen dagligrøykere etter at du fylte 20 år? ........
8.4 Har du røykt/røyker du daglig? ...............
Hvis ALDRI: Hopp til spørsmål 9 (UTDANNING OG ARBEID)
8.5 Hvis du røyker daglig nå, røyker du:
8.6 Hvis du har røykt daglig tidligere, hvor
lenge er det siden du sluttet? Antall år
8.7 Hvis du røyker daglig nå eller har røykt 
tidligere:
4.1 Hvor mange ganger de siste 12 månedene har du selv brukt:
(Sett ett kryss for hver linje)
Allmennpraktiserende lege .......................
Bedriftslege...............................................
Psykolog eller psykiater ............................
(privat eller på poliklinikk)
Annen spesialist (privat eller på poliklinikk)
























Vitamin- og/eller mineraltilskudd? ..........
7.4 Hvor mye drikker du vanligvis av følgende?
(Sett ett kryss pr. linje)
7.5 Drikker du vanligvis brus/cola: Med sukker       1 Uten sukker      2
7.6 Hvor mange kopper kaffe og te drikker du daglig?
(Sett 0 for de typene du ikke drikker daglig)
7.7 Omtrent hvor ofte har du i løpet av det siste året drukket alkohol?
(Lettøl og alkoholfritt øl regnes ikke med)
7.8 Når du har drukket alkohol, hvor mange glass 
eller drinker har du vanligvis drukket?           Antall
7.9 Omtrent hvor mange ganger i løpet av det siste 
året har du drukket så mye som minst 5 glass 











3 g. el. mer
pr.dag









Ja, daglig Iblant Nei
1 2 3 4 5 6
Helmelk, kefir, yoghurt ............











































1 2 3 4
5 6 7 8
7.10 Når du drikker, drikker du da vanligvis: (Sett ett eller flere kryss)
Øl Vin Brennevin
9.1 Hvor mange års skolegang
har du gjennomført? Antall år
(Ta med alle år du har gått på skole eller studert)
9.2 Er du i inntektsgivende arbeid?
9.3 Beskriv virksomheten på det arbeidsstedet (avdelingen) 
der du utførte inntektsgivende arbeid i lengst tid de 
siste 12 mnd. (F.eks. regnskapsbyrå, ungdomsskole, 
barneavd. på sykehus, snekkerverksted, bilverksted, bank, 
dagligvarehandel e.l.)
Virksomhet:
Hvis pensjonert, skriv tidligere hovedvirksomhet og yrke.
Gjelder også 9.4
9.4 Hvilket yrke/tittel har eller hadde du på dette arbeidsstedet? 
(F.eks. sekretær, lærer, industriarbeider, barnepleier, 
møbelsnekker, avdelingsleder, selger, sjåfør e.l.)
Yrke:
9.5 Arbeider du i ditt hovedyrke som selvstendig, som ansatt 
eller som familiemedlem uten fast avtalt lønn?
9.6 Mener du at du står i fare for å miste ditt 
nåværende arbeid eller inntekt de nærmeste 
2 årene?..................................................................







Sykepenger (er sykmeldt) ........................................
Alderstrygd, førtidspensjon (AFP) eller
etterlattepensjon.......................................................
Rehabiliterings-/attføringspenger .............................
Uførepensjon (hel eller delvis)..................................
Dagpenger under arbeidsledighet............................
Sosialhjelp/-stønad ...................................................
Overgangsstønad for enslige forsørgere ..................
Hvor mange sigaretter røyker eller røykte 
du vanligvis daglig? Antall sigaretter
Hvor gammel var du da du begynte å 
røyke daglig? Alder i år




Ja, full tid Ja, deltid Nei1 2 3
Selvstendig Ansatt Familiemedlem
1.3 Har du merket anfall med plutselig endring i 






















2.1 Har du vært plaget med smerter og/eller stivhet 
i muskler og ledd i løpet av de siste 4 ukene?
(Varighet angis bare hvis du har hatt plager)
5.1 Hvor lenge har du samlet bodd i fylket?
(Sett 0 hvis mindre enn et halvt år)
5.2 Hvor lenge har du samlet bodd i kommunen?
(Sett 0 hvis mindre enn et halvt år)
5.3 Hvor bodde du det meste av tiden før du fylte 16 år?




Annet fylke i Norge .... Hvilket:
Utenfor Norge ............ Land:
5.4 Har du flyttet i løpet av de siste fem årene?
Nei Ja, en gang Ja, flere ganger
1 2 3
NEIJA
1.1 Hvordan er helsen din nå? (Sett bare ett kryss)
Dårlig Ikke helt god God Svært god
1 2 3 4
1.4 Får du smerter eller ubehag i brystet når du:
Går i bakker, trapper eller fort på flat mark?.................
1.6 Dersom du stopper, forsvinner smertene da
etter mindre enn 10 minutter? ...................................
1.7 Kan slike smerter opptre selv om du er i ro? ..........
1.5 Hvis du får slike smerter, pleier du da å:










Øvre del av ryggen ...
Korsryggen................
Hofter, ben, føtter ......
Andre steder..............











2.2 Har du noen gang hatt:
Brudd i håndledd/underarm? .....................
Lårhalsbrudd? ............................................
1. EGEN HELSE 3. ANDRE PLAGER 7. MAT OG DRIKKE 8. RØYKING
9. UTDANNING OG ARBEID
4. BRUK AV HELSETJENESTER
5. OPPVEKST OG TILHØRIGHET
6. VEKT
2. MUSKEL OG SKJELETTPLAGER
3.1 Under finner du en liste over ulike problemer. Har du opplevd 
noe av dette den siste uken (til og med i dag)?
(Sett ett kryss for hver plage)
Plutselig frykt uten grunn..........................
Føler deg redd eller engstelig...................
Matthet eller svimmelhet ..........................
Føler deg anspent eller oppjaget..............
Lett for å klandre deg selv........................
Søvnproblemer .........................................
Nedtrykt, tungsindig..................................
Følelse av å være unyttig, lite verd ..........
Følelse av at alt er et slit ..........................









1 2 3 4
7.1 Hvor ofte spiser du vanligvis disse matvarene?
(Sett ett kryss pr. linje)
7.2 Hva slags fett bruker du oftest? (Sett ett kryss pr. linje)
7.3 Bruker du følgende kosttilskudd:
8.1 Hvor lenge er du vanligvis daglig 
tilstede i røykfylt rom? Antall hele timer
8.2 Røykte noen av de voksne hjemme 
da du vokste opp?.................................................
8.3 Bor du, eller har du bodd, sammen med 
noen dagligrøykere etter at du fylte 20 år? ........
8.4 Har du røykt/røyker du daglig? ...............
Hvis ALDRI: Hopp til spørsmål 9 (UTDANNING OG ARBEID)
8.5 Hvis du røyker daglig nå, røyker du:
8.6 Hvis du har røykt daglig tidligere, hvor
lenge er det siden du sluttet? Antall år
8.7 Hvis du røyker daglig nå eller har røykt 
tidligere:
4.1 Hvor mange ganger de siste 12 månedene har du selv brukt:
(Sett ett kryss for hver linje)
Allmennpraktiserende lege .......................
Bedriftslege...............................................
Psykolog eller psykiater ............................
(privat eller på poliklinikk)
Annen spesialist (privat eller på poliklinikk)
























Vitamin- og/eller mineraltilskudd? ..........
7.4 Hvor mye drikker du vanligvis av følgende?
(Sett ett kryss pr. linje)
7.5 Drikker du vanligvis brus/cola: Med sukker       1 Uten sukker      2
7.6 Hvor mange kopper kaffe og te drikker du daglig?
(Sett 0 for de typene du ikke drikker daglig)
7.7 Omtrent hvor ofte har du i løpet av det siste året drukket alkohol?
(Lettøl og alkoholfritt øl regnes ikke med)
7.8 Når du har drukket alkohol, hvor mange glass 
eller drinker har du vanligvis drukket?           Antall
7.9 Omtrent hvor mange ganger i løpet av det siste 
året har du drukket så mye som minst 5 glass 











3 g. el. mer
pr.dag









Ja, daglig Iblant Nei
1 2 3 4 5 6
Helmelk, kefir, yoghurt ............











































1 2 3 4
5 6 7 8
7.10 Når du drikker, drikker du da vanligvis: (Sett ett eller flere kryss)
Øl Vin Brennevin
9.1 Hvor mange års skolegang
har du gjennomført? Antall år
(Ta med alle år du har gått på skole eller studert)
9.2 Er du i inntektsgivende arbeid?
9.3 Beskriv virksomheten på det arbeidsstedet (avdelingen) 
der du utførte inntektsgivende arbeid i lengst tid de 
siste 12 mnd. (F.eks. regnskapsbyrå, ungdomsskole, 
barneavd. på sykehus, snekkerverksted, bilverksted, bank, 
dagligvarehandel e.l.)
Virksomhet:
Hvis pensjonert, skriv tidligere hovedvirksomhet og yrke.
Gjelder også 9.4
9.4 Hvilket yrke/tittel har eller hadde du på dette arbeidsstedet? 
(F.eks. sekretær, lærer, industriarbeider, barnepleier, 
møbelsnekker, avdelingsleder, selger, sjåfør e.l.)
Yrke:
9.5 Arbeider du i ditt hovedyrke som selvstendig, som ansatt 
eller som familiemedlem uten fast avtalt lønn?
9.6 Mener du at du står i fare for å miste ditt 
nåværende arbeid eller inntekt de nærmeste 
2 årene?..................................................................







Sykepenger (er sykmeldt) ........................................
Alderstrygd, førtidspensjon (AFP) eller
etterlattepensjon.......................................................
Rehabiliterings-/attføringspenger .............................
Uførepensjon (hel eller delvis)..................................
Dagpenger under arbeidsledighet............................
Sosialhjelp/-stønad ...................................................
Overgangsstønad for enslige forsørgere ..................
Hvor mange sigaretter røyker eller røykte 
du vanligvis daglig? Antall sigaretter
Hvor gammel var du da du begynte å 
røyke daglig? Alder i år




Ja, full tid Ja, deltid Nei1 2 3
Selvstendig Ansatt Familiemedlem
1.3 Har du merket anfall med plutselig endring i 















Medisin mot høyt blodtrykk ..........................
Kolesterolsenkende medisin ........................
Leser, ser på fjernsyn eller annen
stillesittende beskjeftigelse?.................................................
Spaserer, sykler eller beveger deg på 
annen måte minst 4 timer i uka?..........................................
(Her skal du også regne med gang eller 
sykling til arbeidsstedet, søndagsturer m.m.)
Driver mosjonsidrett, tyngre hagearbeid e.l.? ......................
(Merk at aktiviteten skal vare minst 4 timer i uka)
Trener hardt eller driver konkurranseidrett 
regelmessig og flere ganger i uka?......................................
Ingen Under 1 1-2 3 og mer
10.1 Hvordan har din fysiske aktivitet i fritiden vært 
det siste året?
Tenk deg et ukentlig gjennomsnitt for året.
Arbeidsvei regnes som fritid. Besvar begge spørsmålene.
11.3 Hvor stor interesse viser folk for det du gjør?
(Sett bare ett kryss)
11.4 Hvor mange foreninger, lag, grupper,
kirkesamfunn e.l. deltar du i på fritiden?         Antall
(Skriv 0 hvis ingen)
11.5 Føler du at du kan påvirke det som skjer i 
lokalsamfunnet der du bor? (Sett bare ett kryss)
12.1 Har en eller flere av dine foreldre eller søsken 
hatt hjerteinfarkt (sår på hjertet) eller
angina pectoris (hjertekrampe)? ........................
12.2 Kryss av for de slektningene som har eller har
hatt noen av sykdommene: (Sett kryss for hver linje)
Hjerneslag eller
hjerneblødning.............





12.3 Hvis noen slektninger har diabetes, i hvilken alder fikk de
diabetes (hvis for eks. flere søsken, før opp den som fikk det 
tidligst i livet):
11.2 Hvor mange gode venner har du? Antall venner
Regn med de du kan snakke fortrolig med
og som kan gi deg hjelp dersom du trenger det.
Tell ikke med de du bor sammen med, men 
ta med andre slektninger.
10.2 Angi bevegelse og kroppslig anstrengelse i din fritid. Hvis
aktiviteten varierer meget f.eks. mellom sommer og vinter, så
ta et gjennomsnitt. Spørsmålet gjelder bare det siste året.
(Sett kryss i den ruta som passer best)
1 2 3 4
10. MOSJON OG FYSISK AKTIVITET
11. FAMILIE OG VENNER
12. SYKDOM I FAMILIEN
13. BRUK AV MEDISINER
14. RESTEN AV SKJEMAET SKAL BARE
BESVARES AV KVINNER
13.1 Bruker du?
14.1 Hvor gammel var du da du fikk 
menstruasjon aller første gang? Alder i år
14.2 Hvis du ikke lenger får menstruasjon,
hvor gammel var du da den sluttet? Alder i år
14.3 Er du gravid nå?
14.4 Hvor mange barn har du født? Antall barn
14.5 Bruker du, eller har du brukt?
(Sett ett kryss for hver linje)
13.2 Hvor ofte har du i løpet av de siste 4 ukene brukt
følgende medisiner?
(Sett ett kryss pr. linje)
13.3 For de medisinene som du har krysset av for i pkt. 13.1 og 13.2,























Mors alder Fars alder Brors alder Søsters alder Barns alder
Far Bror Søster Barn
Ingen
av disse
Ja, en del Ja, i liten grad Nei
Har ikke
forsøkt




Med medisiner mener vi her medisiner kjøpt på apotek.





Medisin mot depresjon .............
Annen medisin på resept..........
P-pille/minipille/p-sprøyte............
Hormonspiral (ikke vanlig spiral)
Østrogen (tabletter eller plaster)
Østrogen (krem eller stikkpiller)
Angi navnet og hvilken grunn det er til at du tar/har tatt
disse (sykdom eller symptom):











Navn på medisinen: Grunn til bruk Inntil Ett år
(ett navn pr. linje): av medisinen: 1 år eller mer
Dersom det ikke er nok plass her, kan du fortsette på eget ark som du legger ved.


































Før, men ikke nå Aldri
14.6 Hvis du bruker/har brukt reseptpliktig østrogen:
Hvor lenge har du brukt dette? Antall år
14.7 Hvis du bruker p-pille, minipille, p-sprøyte,
hormonspiral eller østrogen; hvilket merke bruker du?
Personlig innbydelse
Ikke skriv her:
1 2 3 4
Helse- 
undersøkelsen
5.3 (Kommune) (Fylke) (Land)
9.3 (Virksomhet) 9.4 (Yrke) 14.7 (Merke)
1 2 3 4 5
11.1 Bor du sammen med:
Ektefelle/samboer? ......................................
NEIJA
Navn på medisinen: Grunn til bruk Inntil Ett år
(ett navn pr. linje): av medisinen: 1 år eller mer
Medisin mot høyt blodtrykk ...................
Kolesterolsenkende medisin .................
Medisin mot osteoporose (benskjørhet)
Insulin ...................................................
Tabletter mot sukkersyke ......................
Hvor stor interesse viser folk for det du gjør?
(Sett bare ett kryss)
Hvor mange foreninger, lag, grupper,
kirkesamfunn e.l. deltar du i ? Antall
(Skriv 0 hvis ingen)
Bor du: Hjemme? Institusjon/bofellesskap?
Bor du sammen med:
Ektefelle/samboer? .......................
Andre personer? ...........................
Hvor mange gode venner har du?
Regn med de du kan snakke fortrolig med
og som kan gi deg hjelp når du trenger det.
Tell ikke med de du bor sammen med, men ta
med barn og andre slektninger. ...........................
Hvor mange ganger de siste 12 månedene
har du selv brukt:
(Sett ett kryss for hver linje)
Er du trygg på at du kan få
hjelp av helseog hjemme-
tjenesten hvis du trenger det?
E11. BRUK AV HELSETJENESTER
E12. FAMILIE OG VENNER
E13. OPPVEKST OG TILHØRIGHET
E14. BRUK AV MEDISINER
E15. RESTEN AV SKJEMAET SKAL BARE
BESVARES AV KVINNER
Bruker du?
(Sett ett kryss for hver linje)
Hvor gammel var du da du fikk 
menstruasjon aller første gang? Alder i år
Hvor gammel var du da
menstruasjonen sluttet? Alder i år
Hvor mange barn har du født? Antall barn
Bruker du, eller har du brukt østrogenmedisin?
Hvor ofte har du i løpet av de siste 4 ukene brukt
følgende medisiner?














1 2 3 4 5
Med medisiner mener vi her medisiner kjøpt på apotek.
Kosttilskudd og vitaminer regnes ikke med her.
Smertestillende uten resept .......




Annen medisin på resept ...........
Tabletter eller plaster ...................
Krem eller stikkpiller .....................
Angi navnet på de medisinene du bruker nå, og hva grunnen
er til at du tar medisinene (sykdom eller symptom):










Dersom det ikke er nok plass her, kan du fortsette på eget ark som du legger ved.
Hvor lenge har du
brukt medisinen?
Aldri Før Nå
Hvis du bruker østrogen; hvilket merke bruker du nå?
Har du noen gang brukt P-pille? ..........................
E
Ikke skriv her:
E13 (Kommune) (Fylke) (Land) E15 (Merke)
1 2 3 4
Allmennpraktiserende lege................
Spesialist (privat eller på poliklinikk)












Hvor lenge har du samlet bodd i fylket?
Hvor lenge har du samlet bodd i kommunen?
Hvor bodde du det meste av tiden før du fylte 16 år?
(Kryss av for ett alternativ og spesifiser)
Samme kommune .........
Annen kommune
i fylket ............................ Hvilken:
Annet fylke i Norge........ Hvilket:
Utenfor Norge................ Land:
Har du flyttet i løpet av de siste fem årene?


















































Feit fisk (f.eks. laks, 
ørret, makrell, sild)










Har en eller flere av dine foreldre eller søsken hatt:
NEIJA
Hvordan er helsen din nå? (Sett bare ett kryss)
Dårlig Ikke helt god God Svært god
1 2 3 4
Får du smerter eller ubehag i brystet når du:
Går i bakker, trapper eller fort på flat mark? .............
Dersom du stopper, forsvinner smertene da
etter mindre enn 10 minutter?................................
Kan slike smerter opptre selv om du er i ro?.......
Hvis du får slike smerter, pleier du da å:







Hjerteinfarkt (sår på hjertet) eller




E1. EGEN HELSE E3. PLAGER E7. UTDANNING
E8. MAT OG DRIKKE
E9. RØYKING
E10. FUNKSJON OG TRYGGHET
E4. TENNER, MUSKEL OG SKJELETT
E5. MOSJON OG FYSISK AKTIVITET
E6. VEKT
E2. SYKDOM I FAMILIEN
Under finner du en liste over ulike problemer.
Har du opplevd noe av dette den siste uken
(til og med i dag)?
(Sett ett kryss for hver linje)
Plutselig frykt uten grunn ................
Føler deg redd eller engstelig .........
Matthet eller svimmelhet .................
Føler deg anspent eller oppjaget ....
Lett for å klandre deg selv ..............
Søvnproblemer................................
Nedtrykt, tungsindig ........................
Følelse av å være unyttig, lite verd
Følelse av at alt er et slit.................









1 2 3 4
Hvor ofte spiser du vanligvis disse matvarene?
(Sett ett kryss for hver linje)
Bruker du kosttilskudd:
Hvor lenge er du vanligvis daglig 
tilstede i et røykfylt rom? Antall hele timer
Røykte noen av de voksne hjemme 
da du vokste opp?...............................................
Bor du, eller har du bodd, sammen med 
noen dagligrøykere etter at du fylte 20 år? ......
Har du røykt/røyker du daglig?...............
Hvis du ALDRI har røykt daglig;
Hopp til spørsmål E11 (FUNKSJON OG TRYGGHET)
Hvis du røyker daglig nå, røyker du:
Hvis du har røykt daglig tidligere, hvor
lenge er det siden du sluttet? Antall år
Hvis du røyker daglig nå eller har røykt 
tidligere:
Hvor mange tenner har du mistet/trukket? Antall tenner
(Se bort fra melketenner og visdomstenner)
Anslå din vekt da du var 25 år gammel: hele kg
Tran, trankapsler, fiskeoljekapsler .....
Vitamin- og/eller mineraltilskudd .......
Hvor mye drikker du vanligvis av følgende?













1 2 3 4 5 6
Ja, daglig Iblant Nei
Helmelk, kefir, yoghurt.........
Lettmelk, cultura, lettyoghurt


















1 2 3 4 5
1 2 3
1 2 3 4
Hvor mange års skolegang har du 
gjennomført? Antall år
(Ta med alle år du har gått på skole eller studert)
Ville du følt deg trygg ved å ferdes alene
på kveldstid i nærområdet der du bor?
Når det gjelder førlighet, syn og hørsel, kan du:
(Sett ett kryss for hver linje)
Har du på grunn av varige helseproblemer vansker
med å: (Sett ett kryss for hver linje)
Gå en 5 minutters tur i 
noenlunde raskt tempo? ........
Lese vanlig tekst i aviser,
evt. med briller? .....................
Høre hva som blir sagt
i en normal samtale? .............
Bevege deg rundt i egen bolig? ..............
Komme deg ut av boligen på egen hånd?
Delta i foreningsliv eller andre 
fritidsaktiviteter? ......................................
Bruke offentlige transportmidler? ............








Hvor mange sigaretter røyker eller røykte 
du vanligvis daglig? Antall sigaretter
Hvor gammel var du da du begynte å 
røyke daglig? Alder i år
Hvor mange år til sammen har du 
røykt daglig? Antall år
Ja Litt utrygg Svært utrygg
Har du vært plaget med smerter og/eller stivhet 
i muskler og ledd i løpet av de siste 4 ukene?
Nakke/skuldre.........................
Armer, hender ........................
Øvre del av ryggen.................
Korsryggen.............................








Har du noen gang hatt:
Brudd i håndledd/underarm?.....................
Lårhalsbrudd?............................................
Har du falt i løpet av det siste året? (Sett bare ett kryss)
NEIJA







Under 1Ingen 1-2 3 og mer
Hvordan har din fysiske aktivitet vært det siste året?
Tenk deg et ukentlig gjennomsnitt for året.
Besvar begge spørsmålene.
1 2 3 4














1 2 3Kryss av for de slektningene som har eller har
hatt noen av sykdommene: (Sett kryss for hver linje)
Hjerneslag eller
hjerneblødning..............





Hvis noen slektninger har diabetes, i hvilken alder fikk de
diabetes (hvis for eks. flere søsken, før opp den som fikk




Mors alder Fars alder Brors alder
Søsters
alder Barns alder
Far Bror Søster Barn
Ingen
av disse Omtrent hvor ofte har du i løpet av det siste året drukket
alkohol? (Lettøl og alkoholfritt øl regnes ikke med)
Når du har drukket alkohol, hvor mange glass 
eller drinker har du vanligvis drukket? Antall
Omtrent hvor mange ganger i løpet av det siste 
året har du drukket så mye som minst 5 glass 






















1 2 3 4
5 6 7 8
Antall kopper
Hvor mange kopper kaffe og te drikker du daglig?






Feit fisk (f.eks. laks, 
ørret, makrell, sild)










Har en eller flere av dine foreldre eller søsken hatt:
NEIJA
Hvordan er helsen din nå? (Sett bare ett kryss)
Dårlig Ikke helt god God Svært god
1 2 3 4
Får du smerter eller ubehag i brystet når du:
Går i bakker, trapper eller fort på flat mark? .............
Dersom du stopper, forsvinner smertene da
etter mindre enn 10 minutter?................................
Kan slike smerter opptre selv om du er i ro?.......
Hvis du får slike smerter, pleier du da å:







Hjerteinfarkt (sår på hjertet) eller




E1. EGEN HELSE E3. PLAGER E7. UTDANNING
E8. MAT OG DRIKKE
E9. RØYKING
E10. FUNKSJON OG TRYGGHET
E4. TENNER, MUSKEL OG SKJELETT
E5. MOSJON OG FYSISK AKTIVITET
E6. VEKT
E2. SYKDOM I FAMILIEN
Under finner du en liste over ulike problemer.
Har du opplevd noe av dette den siste uken
(til og med i dag)?
(Sett ett kryss for hver linje)
Plutselig frykt uten grunn ................
Føler deg redd eller engstelig .........
Matthet eller svimmelhet .................
Føler deg anspent eller oppjaget ....
Lett for å klandre deg selv ..............
Søvnproblemer................................
Nedtrykt, tungsindig ........................
Følelse av å være unyttig, lite verd
Følelse av at alt er et slit.................









1 2 3 4
Hvor ofte spiser du vanligvis disse matvarene?
(Sett ett kryss for hver linje)
Bruker du kosttilskudd:
Hvor lenge er du vanligvis daglig 
tilstede i et røykfylt rom? Antall hele timer
Røykte noen av de voksne hjemme 
da du vokste opp?...............................................
Bor du, eller har du bodd, sammen med 
noen dagligrøykere etter at du fylte 20 år? ......
Har du røykt/røyker du daglig?...............
Hvis du ALDRI har røykt daglig;
Hopp til spørsmål E11 (FUNKSJON OG TRYGGHET)
Hvis du røyker daglig nå, røyker du:
Hvis du har røykt daglig tidligere, hvor
lenge er det siden du sluttet? Antall år
Hvis du røyker daglig nå eller har røykt 
tidligere:
Hvor mange tenner har du mistet/trukket? Antall tenner
(Se bort fra melketenner og visdomstenner)
Anslå din vekt da du var 25 år gammel: hele kg
Tran, trankapsler, fiskeoljekapsler .....
Vitamin- og/eller mineraltilskudd .......
Hvor mye drikker du vanligvis av følgende?













1 2 3 4 5 6
Ja, daglig Iblant Nei
Helmelk, kefir, yoghurt.........
Lettmelk, cultura, lettyoghurt


















1 2 3 4 5
1 2 3
1 2 3 4
Hvor mange års skolegang har du 
gjennomført? Antall år
(Ta med alle år du har gått på skole eller studert)
Ville du følt deg trygg ved å ferdes alene
på kveldstid i nærområdet der du bor?
Når det gjelder førlighet, syn og hørsel, kan du:
(Sett ett kryss for hver linje)
Har du på grunn av varige helseproblemer vansker
med å: (Sett ett kryss for hver linje)
Gå en 5 minutters tur i 
noenlunde raskt tempo? ........
Lese vanlig tekst i aviser,
evt. med briller? .....................
Høre hva som blir sagt
i en normal samtale? .............
Bevege deg rundt i egen bolig? ..............
Komme deg ut av boligen på egen hånd?
Delta i foreningsliv eller andre 
fritidsaktiviteter? ......................................
Bruke offentlige transportmidler? ............








Hvor mange sigaretter røyker eller røykte 
du vanligvis daglig? Antall sigaretter
Hvor gammel var du da du begynte å 
røyke daglig? Alder i år
Hvor mange år til sammen har du 
røykt daglig? Antall år
Ja Litt utrygg Svært utrygg
Har du vært plaget med smerter og/eller stivhet 
i muskler og ledd i løpet av de siste 4 ukene?
Nakke/skuldre.........................
Armer, hender ........................
Øvre del av ryggen.................
Korsryggen.............................








Har du noen gang hatt:
Brudd i håndledd/underarm?.....................
Lårhalsbrudd?............................................
Har du falt i løpet av det siste året? (Sett bare ett kryss)
NEIJA







Under 1Ingen 1-2 3 og mer
Hvordan har din fysiske aktivitet vært det siste året?
Tenk deg et ukentlig gjennomsnitt for året.
Besvar begge spørsmålene.
1 2 3 4














1 2 3Kryss av for de slektningene som har eller har
hatt noen av sykdommene: (Sett kryss for hver linje)
Hjerneslag eller
hjerneblødning..............





Hvis noen slektninger har diabetes, i hvilken alder fikk de
diabetes (hvis for eks. flere søsken, før opp den som fikk




Mors alder Fars alder Brors alder
Søsters
alder Barns alder
Far Bror Søster Barn
Ingen
av disse Omtrent hvor ofte har du i løpet av det siste året drukket
alkohol? (Lettøl og alkoholfritt øl regnes ikke med)
Når du har drukket alkohol, hvor mange glass 
eller drinker har du vanligvis drukket? Antall
Omtrent hvor mange ganger i løpet av det siste 
året har du drukket så mye som minst 5 glass 






















1 2 3 4
5 6 7 8
Antall kopper
Hvor mange kopper kaffe og te drikker du daglig?
(Sett 0 for de typene du ikke drikker daglig)
Navn på medisinen: Grunn til bruk Inntil Ett år
(ett navn pr. linje): av medisinen: 1 år eller mer
Medisin mot høyt blodtrykk ...................
Kolesterolsenkende medisin .................
Medisin mot osteoporose (benskjørhet)
Insulin ...................................................
Tabletter mot sukkersyke ......................
Hvor stor interesse viser folk for det du gjør?
(Sett bare ett kryss)
Hvor mange foreninger, lag, grupper,
kirkesamfunn e.l. deltar du i ? Antall
(Skriv 0 hvis ingen)
Bor du: Hjemme? Institusjon/bofellesskap?
Bor du sammen med:
Ektefelle/samboer? .......................
Andre personer? ...........................
Hvor mange gode venner har du?
Regn med de du kan snakke fortrolig med
og som kan gi deg hjelp når du trenger det.
Tell ikke med de du bor sammen med, men ta
med barn og andre slektninger. ...........................
Hvor mange ganger de siste 12 månedene
har du selv brukt:
(Sett ett kryss for hver linje)
Er du trygg på at du kan få
hjelp av helseog hjemme-
tjenesten hvis du trenger det?
E11. BRUK AV HELSETJENESTER
E12. FAMILIE OG VENNER
E13. OPPVEKST OG TILHØRIGHET
E14. BRUK AV MEDISINER
E15. RESTEN AV SKJEMAET SKAL BARE
BESVARES AV KVINNER
Bruker du?
(Sett ett kryss for hver linje)
Hvor gammel var du da du fikk 
menstruasjon aller første gang? Alder i år
Hvor gammel var du da
menstruasjonen sluttet? Alder i år
Hvor mange barn har du født? Antall barn
Bruker du, eller har du brukt østrogenmedisin?
Hvor ofte har du i løpet av de siste 4 ukene brukt
følgende medisiner?














1 2 3 4 5
Med medisiner mener vi her medisiner kjøpt på apotek.
Kosttilskudd og vitaminer regnes ikke med her.
Smertestillende uten resept .......




Annen medisin på resept ...........
Tabletter eller plaster ...................
Krem eller stikkpiller .....................
Angi navnet på de medisinene du bruker nå, og hva grunnen
er til at du tar medisinene (sykdom eller symptom):










Dersom det ikke er nok plass her, kan du fortsette på eget ark som du legger ved.
Hvor lenge har du
brukt medisinen?
Aldri Før Nå
Hvis du bruker østrogen; hvilket merke bruker du nå?
Har du noen gang brukt P-pille? ..........................
E
Ikke skriv her:
E13 (Kommune) (Fylke) (Land) E15 (Merke)
1 2 3 4
Allmennpraktiserende lege................
Spesialist (privat eller på poliklinikk)












Hvor lenge har du samlet bodd i fylket?
Hvor lenge har du samlet bodd i kommunen?
Hvor bodde du det meste av tiden før du fylte 16 år?
(Kryss av for ett alternativ og spesifiser)
Samme kommune .........
Annen kommune
i fylket ............................ Hvilken:
Annet fylke i Norge........ Hvilket:
Utenfor Norge................ Land:
Har du flyttet i løpet av de siste fem årene?













































T10. SYKDOM I FAMILIEN
T11. MOBILTELEFON






























1.1 I hvilken kommune bodde du da du fylte 1 år?
(Hvis du ikke bodde i Norge, oppgi hvilket land
i stedet for kommune)







T1. LOKALMILJØ OG BOLIG
Tilleggsspørsmål til helseundersøkelsen
i Troms og Finnmark 2001-2002
Hovedformålet med Helseundersøkelsen er å skaffe ny
kunnskap om hjerte-karsykdommer for å kunne forebygge
dem. I tillegg skal undersøkelsen øke kunnskapen om
kreftsykdommer og plager som f.eks allergier, smerter i
muskulatur og nervøse lidelser. Vi ber deg derfor svare
på noen spørsmål om forhold som kan ha betydning for
risikoen for disse og andre sykdommer.
Skjemaet er en del av Helseundersøkelsen som er god-
kjent av Datatilsynet og forelagt Regional komité for
medisinsk forskningsetikk. Svarene brukes bare til
forskning og behandles strengt fortrolig. 
Opplysningene kan senere bli sammenholdt med
informasjon fra andre offentlige helseregistre etter de
regler som Datatilsynet og Regional komité for medisinsk
forskningsetikk gir.
Hvis du er i tvil om hva du skal svare, sett kryss i den
ruten du synes passer best. 
Det utfylte skjemaet sendes i vedlagte svarkonvolutt.
Portoen er betalt. På forhånd takk for hjelpen!
Med vennlig hilsen
Institutt for samfunnsmedisin   Statens helseundersøkelser
Universitetet i Tromsø
Hvis du ikke ønsker å besvare dette spørreskjemaet,
sett kryss i ruten under og returner skjemaet. Da slipper
du å bli purret på!
Jeg ønsker ikke å besvare spørreskjemaet
T1. LOKALMILJØ OG BOLIG (forts.)







1.8 Hvor ofte tar du vanligvis del i forenings-
virksomhet som f.eks. syklubb, idrettslag,
politiske lag eller andre foreninger? 
(Sett bare ett kryss)
Aldri, eller noen få ganger i året ........................
1-3 ganger i måneden........................................
Omtrent 1 gang i uken .......................................
Mer enn en gang i uken.....................................
For det meste stillesittende arbeid?
(f.eks. skrivebordsarbeid, montering) ................
Arbeid som krever at du går mye?
(f.eks. ekspeditørarb., lett industriarb., undervisning)
Arbeid hvor du går og løfter mye?
(f.eks. postbud, pleier, bygningsarbeider)..........
Tungt kroppsarbeid?










1.3 Hvor stor er din boenhet?   ca. kvm (brutto)
JA
1.4 Er du plaget av: (Sett ett kryss for hver linje)
Fukt, trekk eller kulde i din bolig ............
Andre former for dårlig inneklima ..........
Trafikkstøy (biltrafikk eller fly) ................
Annen støy (bedrift, byggeplass e.l.) .....
Nabostøy................................................
Dårlig drikkevann ...................................
Luftforurensning fra trafikk .....................









12.2 Hvis du fremdeles har menstruasjon eller er gravid:
Hvilken dato startet din siste menstruasjon? 
12.5 Bruker du eller har du brukt p-piller? ..
Hvis JA:
Hvor gammel var du da du
begynte med p-piller?............................
Hvor mange år har du 
til sammen brukt p-piller? ...............Antall år
Dersom du har født:
Hvor mange år brukte du p-piller
før første fødsel? .............................Antall år
Hvis du sluttet å bruke p-piller:
Hvor gammel var du da du sluttet?......
12.6 Når du ser bort fra svangerskap og
barselsperiode, har du noen gang
vært blødningsfri i minst 6 måneder? .
Hvis JA:
Hvor mange ganger?........................
12.7 Hvordan er blødningsforholdene for deg nå?
Jeg har ikke hatt blødninger det siste året
Jeg har regelmessige blødninger.............
Jeg har uregelmessige blødninger...........
12.8 Da du var i 25-29 årsalderen, hvor mange dager
var det vanligvis mellom starten på to blødninger?
Pågikk selve blødningen omtrent
like mange dager hver gang? ...............
Hvor mange dager varte en typisk
menstruasjonsblødning?...............
Takk for hjelpen!
Husk å postlegge skjemaet i dag!
(Hvis flere barn, bruk ekstra ark)
1.6 Hva regner du deg selv som?
(Kryss av for ett eller flere alternativ)
2.1 Hvis du er i lønnet eller ulønnet arbeid, hvordan
vil du beskrive ditt arbeid? (Sett bare ett kryss)
Nei, ikke i det hele tatt .......................................
I liten grad ..........................................................
Ja, stort sett .......................................................





2.2 Kan du selv bestemme hvordan arbeidet ditt (lønnet
eller ulønnet) skal legges opp? (Sett bare ett kryss)
2.3 Har du skiftarbeid, nattarbeid
eller går vakter?
1.7 Føler du at du har nok gode venner?
12.4Bruker du eller har du brukt reseptpliktig
østrogen (tabletter eller plaster)? .........
Hvis JA:
Hvor gammel var du
da du begynte med østrogen? ..............
Hvis du har sluttet å bruke østrogen,
Hvor gammel var du














1.5 Hvilket hjemmespråk hadde dine besteforeldre?





10.1 Kryss av for de slektningene som har eller har hatt
noen av sykdommene: (Sett kryss for hver linje)
10.2 Hvor mange søsken og barn har du?
10.3 Fører sykdom e.l. hos noen i nær familie til
at du vanligvis utfører ekstra omsorgsarbeid?
Hjerteinfarkt (sår på hjertet)
Angina pectoris (hjertekrampe)
Høyt blodtrykk .....................














Ja, stor sett daglig Ja, av og til Nei
1 2 3
11.1 Disponerer du (eier, leier e.l.) mobiltelefon?
Hvis JA:
Hva bruker du mobiltelefonen til, og hvor ofte
bruker du den? (Sett ett kryss for hver linje)
T12. RESTEN BESVARES BARE AV KVINNER
12.1 Hvis du har født barn, fyll ut hvert barns fødselsår, og 
hvor mange måneder du ammet etter fødselen.









Ja, hele tiden Ja, av og til
30 eller
flere
10-29 2-9 1 eller
mindre
Aldri
Antall ganger per døgn
Nei
1 2 3
1 2 3 4 5
JA NEI10.4 Har du/din familie hjemmehjelp
eller hjemmesykepleie?...............................
10.5 Lever din mor?.................
10.6 Lever din far? ...................
JA NEI




12.3 Hvis du ikke lenger har menstruasjon; hvorfor
mistet du menstruasjonen? (Sett ett kryss)
Den stoppet av seg selv ....................................
Operasjon på livmoren.......................................
Opererte bort begge eggstokkene.....................




















T5. MAT OG KOSTTILSKUDD
T6. VEKTEN
T7. SYKDOMMER OG SKADER T8. SYMPTOMER T8. SYMPTOMER (fortsettelse)
T9. MEDISINER
3.1 Røyker du?
Hvis “Ja, av og til”,
Hva røyker du?
Hvis JA:
Hvor mange år har du til sammen
brukt snus?
4.5 Har du i en eller flere perioder de siste 5 årene
drukket så mye alkohol at det har hemmet deg
i yrkeslivet eller sosialt?
5.4 Bruker du følgende kosttilskudd?
8.2 Hoster du omtrent daglig i perioder av året? ...
Hvis JA:
8.11 Pleier du sove om dagen? ..............................
8.12 Hvor ofte har du ufrivillig urinlekkasje?
Aldri ....................................................................
Ikke mer enn en gang i måneden ......................
To eller flere ganger i måneden .........................
Ukentlig eller oftere ............................................
8.1 Har du de siste to ukene følt deg:
(Sett ett kryss for hvert spørsmål)
8.5 Blir du tungpusten i følgende situasjoner?
(Sett ett kryss for hvert spørsmål)
Når du går hurtig på flatmark
eller svak oppoverbakke.........................................
Når du spaserer i rolig tempo
på flatmark..............................................................
Når du vasker deg eller kler på deg .......................
Når du er i hvile ......................................................
8.6 Må du stoppe på grunn av tung pust
når du går i eget tempo på flatmark?................
Er hosten vanligvis ledsaget av oppspytt? ......
Har du hatt slik hoste så lenge som i en 
3 måneders periode i begge de to siste år? ....
7.1 Har du noen gang hatt:
Sett ett kryss for hvert spørsmål. Oppgi også
alderen ved hendelsen. Hvis det har skjedd























Atopisk eksem (f.eks. barneeksem) .......
Håndeksem ............................................
Matvareallergi .........................................
Annen overfølsomhet (ikke allergi).........


















1 2 3 4








Nei 1-2 ganger Mer enn 2 ganger
1 2 3
1 2 3






8.4 Får du smerter i tykkleggen når du går ............
Hvis JA:
Hvor langt kan du gå
før du får smerter? .........................
8.13 Kan du gå ned 10 trappetrinn uten
å holde deg i noe (f.eks. et gelender)............
8.14 Bruker du briller? ............................................
8.15 Bruker du høreapparat? .................................
8.16 Hvordan er hukommelsen?
(Sett ett kryss for hvert spørsmål)
Glemmer du ting du akkurat
har hørt eller lest? .............................................
Glemmer du hvor du har lagt ting? ...................
Er det vanskeligere å huske nå enn før?..........
Skriver du huskelapper oftere nå enn før? .......
Hvis “JA” på ett av disse spørsmålene;









8.7 Har du i løpet av det siste året vært plaget
med smerter og/eller stivhet i muskler og
ledd som har vart i minst 3 måneder
sammenhengende?.............................................
Hvis JA:
Har plagene ført til redusert aktivitet
i fritida? ................................................................






















Har plagene redusert din arbeidsevne det siste året?
(Gjelder også hjemmearbeidende og pensjonister. (Sett ett kryss)
Har du vært sykmeldt pga. disse
plagene det siste året?.............................
Nei/ubetydelig I noen grad I betydelig grad Vet ikke




7.2 Har du, eller har du hatt?





Ja, av og til Nei, aldri
5.3 Hvor stor vekt legger du på å ha et sunt kosthold?
1 2 3 4
Stor Middels Liten Ingen
3.2 Har du brukt, eller bruker du snus daglig?
Ja, nå Ja, tidligere Aldri
9.1 Bruker du, eller har du brukt noen
av følgende medisiner:
9.2 Bruker du noen medisin som du får
som sprøyte (injeksjon)? ..............................
Hvis JA:
Oppgi navn på medisinen (til sprøyte):





bruk 1. gang Aldri
brukt
JA NEI
4.1 Er du totalavholdsmann/-kvinne?................
JA NEI
5.1 Spiser du vanligvis frokost hver dag?.......
7.3 Har du hatt forkjølelse, influensa,
“ræksjuka” eller lignende siste 14 dager?
7.4 Har du i løpet av de siste 3 ukene vært
forkjølet, hatt influensa, bronkitt, lunge-
betennelse, bihulebetennelse eller annen
luftveisinfeksjon?.........................................
7.5 Har du noen gang hatt bronkitt 
eller lungebetennelse? ................................
7.6 Har du i løpet av de siste 2 årene hatt bronkitt
eller lungebetennelse? (Sett bare ett kryss)
4.2 Hvor mange ganger i måneden drikker
du vanligvis alkohol?..................
(Regn ikke med lettøl.
Sett 0 hvis mindre enn 1 gang i måneden)
4.3 Hvor mange glass øl, vin eller brennevin
drikker du vanligvis i løpet av 2 uker?
(Regn ikke med lettøl.
Sett 0 hvis du ikke drikker alkohol)
Antall ganger
år
4.4 I omtrent hvor mange år har ditt
alkoholforbruk vært slik du har
svart i spørsmålene over? år
meter
5.2 Hvor mange ganger i uken
spiser du varm middag?.............................
6.2 Hvilken vekt vil du være tilfreds .....




8.8 Hvor ofte er du plaget av søvnløshet?
(Sett bare ett kryss)
Aldri, eller noen få ganger i året ..........................
1-3 ganger i måneden..........................................
Omtrent 1 gang i uken .........................................









8.9 Hvis du er plaget av søvnløshet månedlig
eller hyppigere, når på året er du mest plaget?
Ingen spesiell tid ..................................................
Særlig i mørketiden..............................................
Særlig i midnattsoltiden........................................
Særlig vår og høst ...............................................
8.10 Har du det siste året vært plaget av søvnløs













Glad og optimistisk ......................
Nedfor/deprimert..........................
Ensom .........................................
8.3 Har du hatt episoder med piping i brystet? .....
Hvis JA:
Har dette oppstått: (Sett ett kryss for hvert spørsmål)
Om natten...............................................................
Ved luftveisinfeksjon...............................................




T5. MAT OG KOSTTILSKUDD
T6. VEKTEN
T7. SYKDOMMER OG SKADER T8. SYMPTOMER T8. SYMPTOMER (fortsettelse)
T9. MEDISINER
3.1 Røyker du?
Hvis “Ja, av og til”,
Hva røyker du?
Hvis JA:
Hvor mange år har du til sammen
brukt snus?
4.5 Har du i en eller flere perioder de siste 5 årene
drukket så mye alkohol at det har hemmet deg
i yrkeslivet eller sosialt?
5.4 Bruker du følgende kosttilskudd?
8.2 Hoster du omtrent daglig i perioder av året? ...
Hvis JA:
8.11 Pleier du sove om dagen? ..............................
8.12 Hvor ofte har du ufrivillig urinlekkasje?
Aldri ....................................................................
Ikke mer enn en gang i måneden ......................
To eller flere ganger i måneden .........................
Ukentlig eller oftere ............................................
8.1 Har du de siste to ukene følt deg:
(Sett ett kryss for hvert spørsmål)
8.5 Blir du tungpusten i følgende situasjoner?
(Sett ett kryss for hvert spørsmål)
Når du går hurtig på flatmark
eller svak oppoverbakke.........................................
Når du spaserer i rolig tempo
på flatmark..............................................................
Når du vasker deg eller kler på deg .......................
Når du er i hvile ......................................................
8.6 Må du stoppe på grunn av tung pust
når du går i eget tempo på flatmark?................
Er hosten vanligvis ledsaget av oppspytt? ......
Har du hatt slik hoste så lenge som i en 
3 måneders periode i begge de to siste år? ....
7.1 Har du noen gang hatt:
Sett ett kryss for hvert spørsmål. Oppgi også
alderen ved hendelsen. Hvis det har skjedd























Atopisk eksem (f.eks. barneeksem) .......
Håndeksem ............................................
Matvareallergi .........................................
Annen overfølsomhet (ikke allergi).........


















1 2 3 4








Nei 1-2 ganger Mer enn 2 ganger
1 2 3
1 2 3






8.4 Får du smerter i tykkleggen når du går ............
Hvis JA:
Hvor langt kan du gå
før du får smerter? .........................
8.13 Kan du gå ned 10 trappetrinn uten
å holde deg i noe (f.eks. et gelender)............
8.14 Bruker du briller? ............................................
8.15 Bruker du høreapparat? .................................
8.16 Hvordan er hukommelsen?
(Sett ett kryss for hvert spørsmål)
Glemmer du ting du akkurat
har hørt eller lest? .............................................
Glemmer du hvor du har lagt ting? ...................
Er det vanskeligere å huske nå enn før?..........
Skriver du huskelapper oftere nå enn før? .......
Hvis “JA” på ett av disse spørsmålene;









8.7 Har du i løpet av det siste året vært plaget
med smerter og/eller stivhet i muskler og
ledd som har vart i minst 3 måneder
sammenhengende?.............................................
Hvis JA:
Har plagene ført til redusert aktivitet
i fritida? ................................................................






















Har plagene redusert din arbeidsevne det siste året?
(Gjelder også hjemmearbeidende og pensjonister. (Sett ett kryss)
Har du vært sykmeldt pga. disse
plagene det siste året?.............................
Nei/ubetydelig I noen grad I betydelig grad Vet ikke




7.2 Har du, eller har du hatt?





Ja, av og til Nei, aldri
5.3 Hvor stor vekt legger du på å ha et sunt kosthold?
1 2 3 4
Stor Middels Liten Ingen
3.2 Har du brukt, eller bruker du snus daglig?
Ja, nå Ja, tidligere Aldri
9.1 Bruker du, eller har du brukt noen
av følgende medisiner:
9.2 Bruker du noen medisin som du får
som sprøyte (injeksjon)? ..............................
Hvis JA:
Oppgi navn på medisinen (til sprøyte):





bruk 1. gang Aldri
brukt
JA NEI
4.1 Er du totalavholdsmann/-kvinne?................
JA NEI
5.1 Spiser du vanligvis frokost hver dag?.......
7.3 Har du hatt forkjølelse, influensa,
“ræksjuka” eller lignende siste 14 dager?
7.4 Har du i løpet av de siste 3 ukene vært
forkjølet, hatt influensa, bronkitt, lunge-
betennelse, bihulebetennelse eller annen
luftveisinfeksjon?.........................................
7.5 Har du noen gang hatt bronkitt 
eller lungebetennelse? ................................
7.6 Har du i løpet av de siste 2 årene hatt bronkitt
eller lungebetennelse? (Sett bare ett kryss)
4.2 Hvor mange ganger i måneden drikker
du vanligvis alkohol?..................
(Regn ikke med lettøl.
Sett 0 hvis mindre enn 1 gang i måneden)
4.3 Hvor mange glass øl, vin eller brennevin
drikker du vanligvis i løpet av 2 uker?
(Regn ikke med lettøl.
Sett 0 hvis du ikke drikker alkohol)
Antall ganger
år
4.4 I omtrent hvor mange år har ditt
alkoholforbruk vært slik du har
svart i spørsmålene over? år
meter
5.2 Hvor mange ganger i uken
spiser du varm middag?.............................
6.2 Hvilken vekt vil du være tilfreds .....




8.8 Hvor ofte er du plaget av søvnløshet?
(Sett bare ett kryss)
Aldri, eller noen få ganger i året ..........................
1-3 ganger i måneden..........................................
Omtrent 1 gang i uken .........................................









8.9 Hvis du er plaget av søvnløshet månedlig
eller hyppigere, når på året er du mest plaget?
Ingen spesiell tid ..................................................
Særlig i mørketiden..............................................
Særlig i midnattsoltiden........................................
Særlig vår og høst ...............................................
8.10 Har du det siste året vært plaget av søvnløs













Glad og optimistisk ......................
Nedfor/deprimert..........................
Ensom .........................................
8.3 Har du hatt episoder med piping i brystet? .....
Hvis JA:
Har dette oppstått: (Sett ett kryss for hvert spørsmål)
Om natten...............................................................
Ved luftveisinfeksjon...............................................
Ved fysisk anstrengelse .........................................
Ved sterk kulde.......................................................
T10. SYKDOM I FAMILIEN
T11. MOBILTELEFON






























1.1 I hvilken kommune bodde du da du fylte 1 år?
(Hvis du ikke bodde i Norge, oppgi hvilket land
i stedet for kommune)







T1. LOKALMILJØ OG BOLIG
Tilleggsspørsmål til helseundersøkelsen
i Troms og Finnmark 2001-2002
Hovedformålet med Helseundersøkelsen er å skaffe ny
kunnskap om hjerte-karsykdommer for å kunne forebygge
dem. I tillegg skal undersøkelsen øke kunnskapen om
kreftsykdommer og plager som f.eks allergier, smerter i
muskulatur og nervøse lidelser. Vi ber deg derfor svare
på noen spørsmål om forhold som kan ha betydning for
risikoen for disse og andre sykdommer.
Skjemaet er en del av Helseundersøkelsen som er god-
kjent av Datatilsynet og forelagt Regional komité for
medisinsk forskningsetikk. Svarene brukes bare til
forskning og behandles strengt fortrolig. 
Opplysningene kan senere bli sammenholdt med
informasjon fra andre offentlige helseregistre etter de
regler som Datatilsynet og Regional komité for medisinsk
forskningsetikk gir.
Hvis du er i tvil om hva du skal svare, sett kryss i den
ruten du synes passer best. 
Det utfylte skjemaet sendes i vedlagte svarkonvolutt.
Portoen er betalt. På forhånd takk for hjelpen!
Med vennlig hilsen
Institutt for samfunnsmedisin   Statens helseundersøkelser
Universitetet i Tromsø
Hvis du ikke ønsker å besvare dette spørreskjemaet,
sett kryss i ruten under og returner skjemaet. Da slipper
du å bli purret på!
Jeg ønsker ikke å besvare spørreskjemaet
T1. LOKALMILJØ OG BOLIG (forts.)







1.8 Hvor ofte tar du vanligvis del i forenings-
virksomhet som f.eks. syklubb, idrettslag,
politiske lag eller andre foreninger? 
(Sett bare ett kryss)
Aldri, eller noen få ganger i året ........................
1-3 ganger i måneden........................................
Omtrent 1 gang i uken .......................................
Mer enn en gang i uken.....................................
For det meste stillesittende arbeid?
(f.eks. skrivebordsarbeid, montering) ................
Arbeid som krever at du går mye?
(f.eks. ekspeditørarb., lett industriarb., undervisning)
Arbeid hvor du går og løfter mye?
(f.eks. postbud, pleier, bygningsarbeider)..........
Tungt kroppsarbeid?










1.3 Hvor stor er din boenhet?   ca. kvm (brutto)
JA
1.4 Er du plaget av: (Sett ett kryss for hver linje)
Fukt, trekk eller kulde i din bolig ............
Andre former for dårlig inneklima ..........
Trafikkstøy (biltrafikk eller fly) ................
Annen støy (bedrift, byggeplass e.l.) .....
Nabostøy................................................
Dårlig drikkevann ...................................
Luftforurensning fra trafikk .....................









12.2 Hvis du fremdeles har menstruasjon eller er gravid:
Hvilken dato startet din siste menstruasjon? 
12.5 Bruker du eller har du brukt p-piller? ..
Hvis JA:
Hvor gammel var du da du
begynte med p-piller?............................
Hvor mange år har du 
til sammen brukt p-piller? ...............Antall år
Dersom du har født:
Hvor mange år brukte du p-piller
før første fødsel? .............................Antall år
Hvis du sluttet å bruke p-piller:
Hvor gammel var du da du sluttet?......
12.6 Når du ser bort fra svangerskap og
barselsperiode, har du noen gang
vært blødningsfri i minst 6 måneder? .
Hvis JA:
Hvor mange ganger?........................
12.7 Hvordan er blødningsforholdene for deg nå?
Jeg har ikke hatt blødninger det siste året
Jeg har regelmessige blødninger.............
Jeg har uregelmessige blødninger...........
12.8 Da du var i 25-29 årsalderen, hvor mange dager
var det vanligvis mellom starten på to blødninger?
Pågikk selve blødningen omtrent
like mange dager hver gang? ...............
Hvor mange dager varte en typisk
menstruasjonsblødning?...............
Takk for hjelpen!
Husk å postlegge skjemaet i dag!
(Hvis flere barn, bruk ekstra ark)
1.6 Hva regner du deg selv som?
(Kryss av for ett eller flere alternativ)
2.1 Hvis du er i lønnet eller ulønnet arbeid, hvordan
vil du beskrive ditt arbeid? (Sett bare ett kryss)
Nei, ikke i det hele tatt .......................................
I liten grad ..........................................................
Ja, stort sett .......................................................





2.2 Kan du selv bestemme hvordan arbeidet ditt (lønnet
eller ulønnet) skal legges opp? (Sett bare ett kryss)
2.3 Har du skiftarbeid, nattarbeid
eller går vakter?
1.7 Føler du at du har nok gode venner?
12.4Bruker du eller har du brukt reseptpliktig
østrogen (tabletter eller plaster)? .........
Hvis JA:
Hvor gammel var du
da du begynte med østrogen? ..............
Hvis du har sluttet å bruke østrogen,
Hvor gammel var du














1.5 Hvilket hjemmespråk hadde dine besteforeldre?





10.1 Kryss av for de slektningene som har eller har hatt
noen av sykdommene: (Sett kryss for hver linje)
10.2 Hvor mange søsken og barn har du?
10.3 Fører sykdom e.l. hos noen i nær familie til
at du vanligvis utfører ekstra omsorgsarbeid?
Hjerteinfarkt (sår på hjertet)
Angina pectoris (hjertekrampe)
Høyt blodtrykk .....................














Ja, stor sett daglig Ja, av og til Nei
1 2 3
11.1 Disponerer du (eier, leier e.l.) mobiltelefon?
Hvis JA:
Hva bruker du mobiltelefonen til, og hvor ofte
bruker du den? (Sett ett kryss for hver linje)
T12. RESTEN BESVARES BARE AV KVINNER
12.1 Hvis du har født barn, fyll ut hvert barns fødselsår, og 
hvor mange måneder du ammet etter fødselen.









Ja, hele tiden Ja, av og til
30 eller
flere
10-29 2-9 1 eller
mindre
Aldri
Antall ganger per døgn
Nei
1 2 3
1 2 3 4 5
JA NEI10.4 Har du/din familie hjemmehjelp
eller hjemmesykepleie?...............................
10.5 Lever din mor?.................
10.6 Lever din far? ...................
JA NEI




12.3 Hvis du ikke lenger har menstruasjon; hvorfor
mistet du menstruasjonen? (Sett ett kryss)
Den stoppet av seg selv ....................................
Operasjon på livmoren.......................................
Opererte bort begge eggstokkene.....................



















Appendix C. Questionnaires in the intervention study with high doses 
of cholecalciferol 
1. Food frequency questionnaire, Norwegian 
2. Physical activity questionnaire, Norwegian and English 





























Navn:                                    ID nr:                   Dato:                      Baseline        12 mnd 
 
 
INTERNASJONALT SPØRRESKJEMA OM FYSISK AKTIVITET 
 
Vi ønsker å finne ut hva slags fysisk aktivitet folk gjør som del av sitt hverdagsliv. 
Spørsmålene går på hvor mye tid du var i aktivitet i løpet av de siste 7 dagene. Vennligst svar 
på alle spørsmålene, selv om du ikke betrakter deg som en aktiv person. Vennligst tenk på 
aktiviteter du gjør på jobb, som del av hus eller utearbeid, for å komme fra sted til sted, og i 
fritiden i forbindelse med rekreasjon, mosjon eller idrett. 
 
Tenk på all intens fysisk aktivitet du gjorde i løpet av de siste 7 dagene.  Med intens fysisk 
aktivitet menes aktivitet som krever innsats, og som gjør at du blir mye mer tungpusten enn 
vanlig. Tenk kun på fysisk aktivitet som du holdt på med i minst 10 minutter om gangen. 
 
 
1. I løpet av de siste 7 dagene, på hvor mange av dagene utførte du intens fysisk 
aktivitet så som tunge løft, gravearbeid/snømåking, aerobics, løping eller rask sykling/ 
skigåing? 
 
____ dager per uke 
 




2. Hvor mye tid brukte du vanligvis på slik intens fysisk aktivitet i løpet av en av disse 
dagene? 
 
_____ timer per dag             (eller _____ minutter per dag) 
 




Tenk på all moderat (mindre intens) fysisk aktivitet du gjorde i løpet av de siste 7 dagene. 
Med moderat aktivitet menes aktivitet som krever middels innsats og som gjør at du puster 
litt tyngre enn vanlig. Tenk kun på fysisk aktivitet som du holdt på med i minst 10 minutter 
om gangen. 
 
3. I løpet av de siste 7 dagene, på hvor mange dager utførte du moderat aktivitet, så som 
bæring, rolig sykling/skigåing eller lett jogging? Ikke ta med gåing/spaserturer. 
 
____ dager per uke 
 
               Ingen moderat fysisk aktivitet   →  Gå rett til spørsmål 5 
 
4. Hvor mye tid brukte du vanligvis på moderat fysisk aktivitet i løpet av en av disse 
dagene? 
 
_____ timer per dag             (eller _____ minutter per dag) 
 




Tenk på tiden du har brukt på gåing/spaserturer i løpet av de siste 7 dagene. Det inkluderer 
gåing på jobb, hjemme, for å komme fra sted til sted, og annen gåing som du har gjort for 
rekreasjon, idrett, mosjon, eller som fritidsaktivitet. 
 
 
5. I løpet av de siste 7 dagene, på hvor mange dager gikk du minst 10 minutter om 
gangen? 
 
_____ dager per uke 
 
               Ingen gåing   →  Gå rett til spørsmål 7 
 
 
6. Hvor mye tid brukte du vanligvis på å gå i løpet av en av disse dagene? 
 
_____ timer per dag             (eller _____ minutter per dag) 
  




Det siste spørsmålet handler om hvor mye tid du sitter i ro i løpet av hverdagene de siste 7 
dagene. Inkluder tid på jobb, hjemme, og i forbindelse med fritid. Det kan omfatte sitting ved 
skrivebord, besøk hos venner, lesing, eller å sitte eller ligge og se på TV. 
 
 
7. I løpet av de siste 7 dagene, hvor mye satt du i ro på hverdagene? 
 
_____ timer per dag             (eller _____ minutter per dag) 
 
                vet ikke/usikker 
 






 SHORT LAST 7 DAYS SELF-ADMINISTERED version of the IPAQ.  Revised August 2002. 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person.  Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you breathe 
much harder than normal.  Think only about those physical activities that you did for at 
least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one 
of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal.  Think only about those physical activities that you did 
for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles tennis?  
Do not include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
 SHORT LAST 7 DAYS SELF-ADMINISTERED version of the IPAQ.  Revised August 2002. 
4. How much time did you usually spend doing moderate physical activities on one 
of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
The last question is about the time you spent sitting on weekdays during the last 7 
days.  Include time spent at work, at home, while doing course work and during leisure 
time.  This may include time spent sitting at a desk, visiting friends, reading, or sitting or 
lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 





Navn;__________________________________ Alder:________ Kode:__________ Dato_____________ 
 
INSTRUKSJON: I dette spørreskjemaet vil du finne setninger inndelt i grupper. Vennligst les alle 
setningene innenfor hver gruppe nøye. Deretter velger du den setningen i hver gruppe som best beskriver 
hvordan du har følt deg DE SISTE TO UKENE, I DAG INKLUDERT. Sett så en ring rundt tallet utenfor 
setningene du har valgt. Dersom flere setninger innenfor samme gruppe synes å passe like godt, sett en 
ring rundt tallene til hver av dem. 
Husk å lese alle setningene innenfor en gruppe før du velger, og pass på at du gir svar innenfor alle 
gruppene. 
 
1. 0 Jeg føler meg ikke trist. 
1 Jeg er lei meg eller føler meg trist. 
 2 Jeg er lei meg eller trist hele tiden og klarer ikke å komme ut av denne tilstanden. 
3 Jeg er så trist eller ulykkelig at jeg ikke holder det ut. 
 
2. 0 Jeg er ikke særlig pessimistisk eller motløs overfor fremtiden. 
1 Jeg føler meg motløs overfor fremtiden. 
2 Jeg føler at jeg ikke har noe å se frem til. 
3 Jeg føler at fremtiden er håpløs og at forholdene ikke kan bedre seg. 
 
3. 0 Jeg føler meg ikke som et mislykket menneske. 
1 Jeg føler at jeg har mislykkes mer enn andre mennesker. 
2 Når jeg ser tilbake på livet mitt, ser jeg ikke annet enn mislykkethet. 
3 Jeg føler at jeg har mislykkes fullstendig som menneske. 
 
4. 0 Jeg får like mye tilfredsstillelse ut av ting som før. 
1 Jeg nyter ikke ting på samme måte som før. 
2 Jeg får ikke ordentlig tilfredsstillelse ut av noe lenger. 
3 Jeg er misfornøyd eller kjeder meg med alt. 
 
5. 0 Jeg føler meg ikke særlig skyldbetynget. 
1 Jeg føler meg skyldbetynget en god del av tiden. 
2 Jeg føler meg temmelig skyldbetynget mesteparten av tiden. 
3 Jeg føler meg skyldbetynget hele tiden. 
 
6. 0 Jeg har ikke følelsen av å bli straffet. 
 1 Jeg føler at jeg kan bli staffet. 
2 Jeg forventer å bli straffet. 
3 Jeg føler at jeg blir straffet. 
 
7. 0 Jeg føler meg ikke skuffet over meg selv. 
1 Jeg er skuffet over meg selv. 
2 Jeg avskyr meg selv. 
3 Jeg hater meg selv. 
 
8. 0 Jeg føler ikke at jeg er noe dårligere enn andre. 
1 Jeg kritiserer meg selv for mine svakheter eller feilgrep. 
2 Jeg bebreider meg selv hele tiden for mine feil eller mangler. 
3 Jeg gir meg selv skylden for alt galt som skjer. 
 
9. 0 Jeg har ikke tanker om å ta livet mitt. 
1 Jeg har tanker om å ta livet mitt, men jeg vil ikke omsette dem i handling. 
2 Jeg ønsker å ta livet mitt. 
3 Jeg ville ta livet mitt om jeg fikk sjansen til det. 
 
10. 0 Jeg gråter ikke mer enn vanlig. 
1 Jeg gråter mer nå enn jeg gjorde før. 
2 Jeg gråter hele tiden nå. 





11. 0 Jeg er ikke mer irritert nå enn ellers. 
1 Jeg blir lettere ergerlig eller irritert enn før. 
2 Jeg føler meg ganske irritert en god del av tiden. 
3 Jeg blir ikke irritert i det hele tatt over ting som pleide å irritere meg. 
 
12. 0 Jeg har ikke mistet interessen for andre mennesker. 
1 Jeg er mindre interessert i andre mennesker enn jeg pleide å være. 
2 Jeg har mistet det meste av min interesse for andre mennesker. 
3 Jeg har mistet all interesse for andre mennesker. 
 
13. 0 Jeg tar avgjørelser omtrent like lett som jeg alltid har gjort. 
1 Jeg forsøker å utsette det å ta avgjørelser mer enn tidligere. 
2 Jeg har større vanskeligheter med å ta avgjørelser enn før. 
3 Jeg klarer ikke å ta avgjørelser i det hele tatt lenger. 
 
14. 0 Jeg føler ikke at jeg ser dårligere ut enn jeg pleide å gjøre. 
1 Jeg er bekymret for at jeg ser gammel eller lite tiltrekkende ut. 
2 Jeg føler at det er varige forandringer i mitt utseende som får meg til å se lite tiltrekkende 
ut. 
3 Jeg tror at jeg ser stygg ut. 
 
15. 0 Jeg kan arbeide omtrent like godt som før. 
1 Det kreves en ekstra anstrengelse for å ta fatt på noe. 
2 Jeg må presse meg selv meget hardt for å gjøre noe. 
3 Jeg klarer ikke å gjøre noe arbeid i det hele tatt. 
 
16. 0 Jeg sover like godt som ellers. 
1 Jeg sover ikke så godt som før. 
2 Jeg våkner 1-2 timer tidligere enn ellers og har vanskelig for å sovne igjen. 
3 Jeg våkner flere timer tidligere enn jeg pleide og får ikke sove igjen. 
 
17. 0 Jeg blir ikke fortere trett enn ellers. 
1 Jeg blir fortere trett enn før. 
2 Nesten alt jeg gjør, blir jeg trett av. 
3 Jeg er for trett til å gjøre noe som helst. 
 
18. 0 Matlysten min er ikke dårligere enn ellers. 
1 Matlysten min er ikke så god som den var før. 
2 Matlysten min er mye dårligere nå. 
3 Jeg har ikke matlyst i det hele tatt lenger. 
 
19. 0 Jeg har ikke gått ned meget i vekt, om i det hele tatt noe, i den senere tid. 
 1 Jeg har tatt av mer enn 2 kg.    Jeg prøver bevisst å gå ned i  
 2 Jeg har tatt av mer enn 4 kg.    vekt ved å spise mindre. 
 3 Jeg har tatt av mer enn 6 kg.    Ja______, Nei_______ 
 
20. 0 Jeg er ikke mer bekymret for helsen min enn vanlig. 
1 Jeg er bekymret over fysiske plager som verking og smerter; eller urolig mage; eller 
forstoppelse. 
2       Jeg er meget bekymret over mine fysiske plager og det er vanskelig å tenke på          
      stort annet.          
3       Jeg er så bekymret over mine fysiske plager at jeg ikke klarer å tenke på noe annet 
 
21. 0 Jeg har ikke merket noen forandring i mine seksuelle interesser i det siste. 
1 Jeg er mindre interessert i sex enn jeg var før. 
2 Jeg er mye mindre interessert i sex nå. 
3 Jeg har helt mistet interessen for sex.  
 
Appendix D. Copy of internet pages from the Tromsø Study 
1. Invited subjects and participants in the Tromsø studies, information from 2004 
2. Invited subjects and participants in the Tromsø studies, information from 2005 





Tromss-undersskelsen ble startet i 1974 pk bakgrunn av den hoye dodeligheten av hjerte- og karsykdommer i Nord-Norge.
Hensikten var primeert 6 finne forklaringer pi dette (6rsaker) samt utvikle metoder for A forebygge hjerteinfarkt og hjerneslag
hvert er undersskelsen utvidet til ogsA A omfatte mange andre sykdomsgrupper som revmatiske lidelser, nevrologisk sykdom,
hudsykdom, sykdom i mage/tarm, kreft og osteoporose (beinskjorhet).
Undersskelsen er lagt opp som gjentatte helseundersokelser av store deler av befolkningen i kommunen:
I 1974 (6595 menn i alderen 20-49 6r),
i 1979-80 (16610 menn og kvinner i alderen 20-54 6r),
i 1986-87 (21826 menn og kvinner i alderen 12-62 hr),
i 1994-95 (27159 menn og kvinner i alderen 25-99 6r).
Av de 35443 inviterte i 1994-95, mstte 77oh.
Alle mellom 55 og 75, samt et utvalg pi 5-10% av de som var ialderen 25-54 og 75-85 6r, f ikk ti lbud om et nytt
oppmote for spesialundersokelser. 7965 personer mofie til denne andre screeningrunde i 1994-95 (78oio av
innkallingsfilen som var planlagt invitert til en andre screening). I utvalget som fikk hjerte- karrelaterte
undersskelser som ultralyd av hjerte og kar og EKG (6891 personer) var oppmoteprosenten 88% pga hoyere alder i
utvalget.
S i s tehe l seunde rsske l seb leg iennomfo f t i 200 l . 8 l 23  men-nogkv inne r i a l de ren30 -89Arde l t ok . i nnka l l i ngs f i l enbes toava l l e
hjemmehorende i Tromso kommune som var i l ive og hadde deltatt ved den andre screeningrunde ved helseundersskelsen i 1994-
95 (Tromsoundersokelsesutvalget) eller Slte 30,40,45, 60 eller 75 6r i lapet av 2001(SHUS utvalget). Dette utgjorde 10419
personer hvorav 78oh matte. For Tromsoundersokelsesutvalget var oppmotet 89%o g for SHUS utvalget 56% (til dels overlappende
ulvatg t .
n-ru-und..rrkelsen har gitt mye infbrmasjon om s6kalte risikofaktorer for de vanligste alvorlige sykdommer. Kort kan nevnes
bvrydningen av HDL-kolesterol ("det gode kolesterol"), at fusisk aktivitet beskytter mot flere av de vanligste kreftformer og
hvordan kokekaffe hever kolesterolet.
Trolig kan Tromss-undersskelsen ta noe av rren for at forekomsten av hjerteinfarkt har g6tt ned sA markant.
Undersskelsen giennomfores i samarbeid mellom ISM. Folkehelseinstituttet, Regionsykehuset i Tromso og Tromso kommune.
Delprosjekter (pdf)
Sp s r r es kjeaue! o g da lunenl s $j q1
Publiftasjonslistq
Personer som onsket publikasjoner, vil vite mel om eller onsker d vurdere Tromss-undersakelsen som utgangspunkt for mulig
s t u d ent o p p gav e, b e s b eny tt e m a i I a dr es s e n : t r oms o u s(@js m, u it. n o
eller telefonkontakt med konsulent Gerd Furumo - tA 77 64 48 89
Det Side I av I
. Etter
http ://www. i sm. uit. no/tromso 5 / 16.04.04

med-befolkning - - Tromss V
Tromsa V
Tromso-V ble gjennomfgrt i  2OO1. I alt  deltok 8130 menn og
kvinner i  alderen 30 - 89 Ar. To grupper personer ble invitert.
Den storste gruppen av innkalte besto av 5961 menn og kvinner
som var  a l le  personene iTromso kommune som hadde del ta t t
ved sp_esialundersgkelsel i 1994-95
("Tromsou ndersokelsesutva lget").
En noen mindre gruppe pE : :OS menn og kv inner  besto av personer
som Folkehelse inst i tu t te t  (FHI)  Onsket  3  undersgke som en del  av s in
landsomfattende helseundersokesle av personer i aldergruppene 30,
40,  45,60 e l ler  75 3r  ( "FHI  utva lget" ) ,
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Responsraten b lant  personer  som hadde tat t  de l  i  spesia lundersgkelsen
iTromsg-IV (Tromsoundersokelsesutvalget) var meget hay, 89 o/o,
mens det var lavere blant personer i SHUS-utvalget, 56 o/o, og sarl ig
lav b lant  30 3r  gamle menn (36 o/o) .
Undersgkelsesmetoder og m&linger
Med innKatl ingen fulgte det et sporreskjema p3 3 sider. Sporreskjemaet
var noe ul ikt for personer uder 70 3r og for personer Z0 Sr qg eldle.
Sporresk jemaet  ink luder te sporsmSl  om bl .a .  genere l l  he lset i ls tand,
egne sykdommer og sykdommer i  fami l ien,  muskel -smerter  og
psykiske plager, bruk av helsevesenet, kosthold og alkoholbruk, passiv
royking og egne roykevaner, fysisk aktivitet i  fr i t iden, utdanningsnivS
og bruk av medisin. Personer som kom ti l  undersokelsen f ikk utdelt et
nyttsI@lregkjerna som de skulle fyl le ut og sende t i lbake med posten.
http ://uit. no/med-befolkning/tromsov/?Print:friendly 25.07.2005
med-befolkning - - Tromss V
Al le  som mot te,  g jennomgikk bare en re la t iv t  enkel  undersokelse
bestSende av mSling av hoyde, vekt, midje og hofteomkrets, samt
blodtrykk og det ble tatt en blodprove for 3 mSte serum total
kolesterol, HDL kolesterol, tr iglyserider og glukose.
De av Tromsoundersokelsesutvalget som motte , 89 o/o av de inviterte,
f ikk  inv i tas jon t i l  en langt  mer omfat tende undersokelse
(sLesjalundersokelsen) pEsamme mSte som i Tromso-IV,
Universitetet i Tromso, Det medisinske fakultet,  9037 Tromso, t l f  .776 446Of
Oppdatert av Brigt Dale den 25.04,2005 15:33
Ansvarl ig redaktor: konst. fakultetsdir.  Ei l i f  Ni lssen
Side2 av 2
http ://uit.no/med-befolkning/tromsov/?Print=friendly 2s.07.2005
med- tu ->Tromss lV
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Trcmss lV
Tromso-lV, som ble gjennomfort i 1994-95, er den storste av Tromso-undersskelsene
og inkf uderer 27 158 personer (12 865 menn og '14 293 kvinner i alderen 25-97 2rl.
Af fe i Tromss som var 25 Ar eller eldre (fodt tar 19701 ble invitert t i l  undersskelsen.
Deltagelse i Tromss-lV-undersskelsen, 1994-95
% %
menn kvinner
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Hvis man ikke regner med inviterte som hadde flyttet eller dsde lar undersokelsen, kom 77
o/o av de inviterte.
Undersskelsesmetoder og mAlinger
Med inr:k*il i t;ten fulgte det et kort sL.i lrr*skjer:la. Det inkluderte sporsm6l om bl.a. generell
helseti lstand, iagnostisert hjerte-karsykdom eller diabetes samt hjertesykdom i familien,
egne muskelsmerter og psykiske plager, passiv royking og egne roykevaner, fysisk
aktivitet i fr it iden, bruk av kaffe, alkohol og fett p6 brodskiver, utdanningsnivA og
arbeidssituasjon. Det ble foretatt m6ling av hoyde, vekt og blodtrykk og det ble tatt en
blodprove for 6 m6le serum total kolesterol, HDL kolesterol, tr iglyserider, gamma-
glutamyltransferase (GT), hemoglobin og blodcelle-antall ("plot"). Personer som kom ti l
undersskelsen fikk utdelt et sporreskjema som de skulle fylle ut og sende ti lbake med
posten. Dette sporreskjemaet var ulikt for personer -rnrJer 70 ar og de som var ltJ ar +llet
e l i i ie  .
Alle som var i aldersgruppen 55-74 ir, samt et utvalg pA 5-10% av de som var i alderen
25-54 og 75-85 dr, fikk tilbud om A fi gjennomgA en meget omfattende
s p e s l a i l l t 0 e r s c k e i s e ' | a | t m o t t e 7 9 6 5 p e r s o n e r t i | d e n n e . >
Hva fant vi?
Tromso-lV-undersskelsen gav mulighet for en rekke longitudinelle studier der opplysninger
fra tidligere undersskelser kunne knyttes ti l  opplysninger som ni ble samlet. For eksempel
kunne man n6 vise hvordan alderen p6virker utviklingen av fedme (Jacobsen et al, 2001)
over en 20-Arsperiode, og om personer som i 1979 hadde hoy kolesterol ogs6 hadde det
15 Ar  senere (Wi lsgaard et  a l ,  2001).
http : //uit. no/tromsoundersokel sen/tromso4i2 29.06.2007
med- tu ->T romssV
Tromso V
Tromso-V bte giennomfsrt i 2001 . I alt deltok 8130 menn og kvinner i alderen 30 - 89
ir. To grupper personer ble invitert. Den storste gruppen av innkalte besto av 6961
menn og kvinner som var alle personene i Tromso kommune som hadde deltaft ved
spesialundersokelsen i 1 994-95 ("Tromsoundersokelsesutvalget").
En noen mindre gruppe pA 1916 menn og kvinner besto av personer som
Folkehelseinstituttet (FHl) snsket 6 undersoke som en del av sin landsomfattende
helseundersskelse av personer i aldergruppene 30, 40, 45, 60 eller 75 ir ("FHl utvalget").
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Responsraten blant personer som hadde tatt del i spesialundersskelsen i Tromso-lV
(fromsoundersokelsesutvalget) var meget hoy, 89 %, mens det var lavere blant personer i
SHUS-utvalgel,57 o/o, og sarlig lav blant 30 6r gamle menn (38 %).
Undersokelsesmetoder og mili nger
Med innkalhngerr fulgte det et sporreskjema p6 3 sider. Sporreskjemaet var noe ulikt for
personer under 70 ar og for personer 70 zir og eldre. Sporreskjemaet inkluderte sporsm6l
om bl.a. generell helseti lstand, egne sykdommer og sykdommer ifamilien, muskel-smerter
og psykiske plager, bruk av helsevesenet, kosthold og alkoholbruk, passiv royking og egne
roykevaner, fysisk aktivitet i fr it iden, utdanningsniv6 og bruk av medisin. Personer som
kom ti l undersokelsen fikk utdelt et rrytt sporresklema som de skulle fylle ut og sende
tilbake med Dosten.
Alle som motte, gjennomgikk bare en relativt enkel undersokelse best6ende av m6ling av
hoyde, vekt, midje og hofteomkrets, samt blodtrykk og det ble tatt en blodprsve for 6 mSle
serum total kolesterol, HDL kolesterol, tr iglyserider og glukose.
De av Tromssundersskelsesutvalget som motte, 89 % av de inviterte, f ikk invitasjon ti l  en
langt mer omfattende undersokelse (spesialLrnde rsotelsen) p6 samme m6te som i
Tromss-lV.
Oppdatert av Errgl Dale den 20.04.2006 Lt:29
Ansvarl ig redaktgr: Inger Njolstad
http ://uit. no/tromsoundersokel sen/tromso5/?Print:friendly 31.05.2007
 
 
 
